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INTRODUCTION 
This story begins with the revolution in Iran in the 1979 and charts my journey 
from early rebellion against the status quo, to coming to the UK to learn English 
and get an education through training in a cytology laboratory where I learned 
about cytology both as an art and a science.  
 
The story continues with my rise in cytology and my challenges on the way. It 
shares the learning from 13 public works which shows how I have made a 
difference to my profession by helping to: define its standards and boundaries; 
extend those boundaries; develop educational practices and produce textbooks 
and training materials that are used throughout the profession; and improve 
diagnostic services that have led to improved quality and reduced costs. 
 
Finally, I reflect on the implications of what I have learned for my profession and 
my own practice. 
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CHAPTER 1 THE EARLY YEARS–ALL ABOUT ME 
THE REVOLUTIONARY YEARS 
I was born in Iran in 1964. Living through the 1979 Iranian revolution had a 
profound effect on my life and most likely shaped my personality to what I am 
today, including a taste for challenging the status quo.  
 
The revolution grew from a small gathering of people to a large populist 
movement where millions were on the streets holding protests which eventually 
led to the overthrow of the Shah. My own personal experience of the revolution 
was the first days of the high school, when the senior boys had started a loud 
demonstration during lunch break chanting slogans against the Shah. Later I 
became more involved in street demonstrations.  
 
My parents grew concerned that as a strong-willed and rambunctious teenager, I 
would soon run foul of the strict new public rules and get into trouble with the 
authorities. My parents decided that for my own safety I should move to the UK 
and live with my brother who was finishing the first year of his chemistry degree. I 
was not happy about this decision, as I knew that I would probably be leaving 
Iran for good. With a heavy heart I said goodbye to friends and family and in 
August 1979 left Iran.  I did return to Iran, but it was not until 2007, some 28 
years later. 
 
THE BEGINNING OF MY CAREER AS A BIOMEDICAL SCIENTIST 
I arrived in London in 1979, and studied English, O-levels, A-levels, including A-
level chemistry. My chemistry teacher suggested that I should apply for a job that 
offered on the job training. He found a recent job advert for hospital medical 
laboratory scientific officers (MLSOs) as they were called those days. 
In September 1983 I applied for posts as a trainee MLSO and discovered that 
there were a number of different laboratory disciplines covering various 
pathology disciplines:  
 
microbiology (microorganisms and  bacteria),  
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haematology (study of blood cells)  
clinical chemistry (chemistry of blood and body fluids body fluids)  
histology (study of tissues)  
cytology (study of cells) 
 
I applied for 10 jobs and was invited for two interviews. My first interview was 
with a clinical chemistry department. This discipline even in 1983 was highly 
automated and did not appeal to me. My second interview was with the histology 
Department of Hammersmith hospital. The manager (called senior chief MLSO) 
was a very charismatic man and sold me the job at the interview.  
 
The way he portrayed the job was very different to what I discovered after 
working there for a few months.  He correctly told me that I would be attending 
college for five years and eventually gain the fellowship of Institute of Biomedical 
Sciences (IBMS). What was not quite accurate was about the job itself; I was 
given the impression that I would have a role in diagnosis, but I soon discovered 
that as a MLSO I would only be involved in preparing slides of tissues for a 
pathologist to report on and make the diagnosis.  
 
The next five years (1983-1988) at Hammersmith hospital were very enjoyable, 
interesting and educational. In those days NHS laboratories were adequately 
staffed and sufficient time was allocated to training. All trainee MLSOs attended 
college to study for the Higher National Certificate (HNC) in Medical Laboratory 
Sciences. The course included both practical and theoretical components. The 
usual mode of study was to attend as a day release student for the theoretical 
component and two evening classes at a hospital laboratory for practical training. 
The course was well designed with a good balance of practical and theoretical 
teaching. I completed the HNC in 1986 and obtained a merit grade in histology 
and biochemistry. 
 
In September 1986 I began studying for the IBMS Special Examination that led to 
the Fellowship of the Institute of Biomedical Sciences (FIBMS). This was a very 
different course to the HNC. It was taught at a much higher academic level. 
There was no longer a practical component, but a great depth of theory was 
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taught by distinguished lecturers who were senior members of the profession.  
The subject included pathology (study of disease), histopathology (study of 
disease under the microscope) and electron microscopy (study of cells under 
electron microscope).  I enjoyed this course, and socialising with lecturers after 
classes gave me an insight into the profession. Some of the lecturers were 
relatively young and their enthusiasm was infectious.  
 
FIRST AWARENESS OF LIMITATIONS OF BEING A BIOMEDICAL 
SCIENTIST 
This period was also probably the first time that I began to feel frustrated at work, 
as I could not apply the theory that I had learned. I also started doubting whether 
I belonged to a true profession. I had read somewhere that professional people 
had autonomy in their practice, but as a biomedical scientist my practice was 
limited to activities that were allowed under the direction of a medical doctor 
(pathologist). I eventually gained the courage to ask the laboratory manager who 
had employed me in 1983: “is biomedical science a true profession?” He was a 
very well respected senior chief MLSO and was surprised by this question. He 
told me that once I obtained the Fellowship of IBMS I will be able to apply for 
senior positions.    
 
Hammersmith hospital also showed me a side of the medical profession that I 
was not familiar with: a very autocratic and hierarchical system. I later found out 
that all the medical doctors were employed by the Royal Postgraduate Medical 
School (RPMS). This independent medical school based at Hammersmith 
hospital was a leading centre for postgraduate education in UK, but closed after 
1997 when it was assimilated into Imperial College. The senior academic staff of 
the school provided consultant services and academic leadership for 
Hammersmith hospital. Therefore most of the consultant pathologists were 
“professors” and I felt their treatment of more junior doctors and technical staff 
was unreasonably harsh as they were often asked to carry out menial jobs in the 
department.  
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FROM HISTOLOGY TO CYTOLOGY  
One of my duties as a histology MSLO was attending frozen section procedures. 
This procedure is used during a surgical operation where a piece of fresh tissue 
is submitted for urgent microscopic diagnosis usually to confirm cancer, or to 
confirm if the cancer has been fully excised. The process involves slicing a piece 
of tissue and freezing it to make it hard before fine slivers could be cut and 
stained for examination by a pathologist. The technical process usually takes 
about five minutes. I had learned from a histology text bookthat cytological 
preparation could be prepared by touching the cut surface of the tissue against a 
glass slide. This tissue imprint can then be stained and examined under the 
microscope. The process is much faster that the routine frozen section but does 
not give details of tissue architecture that is needed for specific diagnosis.   
 
The Head of Cytology had noted that while he was waiting for the frozen section 
sample, I was often busy looking at the cytology preparation that I had made. 
One day he said that if I was interested in cytology, maybe I should consider 
moving to his department and retraining in cytology. I told him that I felt very 
frustrated about the lack of autonomy in histology. He said that I would be trained 
to look at cervical smears and in time would report the negative cases. He also 
told me that I would have the opportunity to look at diagnostic cases (non-
gynaecological) cytology.  
 
So, though the Chief MLSO was not happy with my going, I joined the cytology 
laboratory.  The lab was a very different environment to histology. The technical 
aspect of the work was minimal and most of the time was spent looking down the 
microscope “screening”.  The laboratory also offered a very unusual service in 
that MLSOs attended clinics to help the clinician collect the sample. This service 
was called fine needle aspiration service (FNA service) after the technique which 
involved removing small tissue biopsies using a fine needle.   This service 
allowed me to have some patient contact, as previously samples were bits of 
tissue in a pot, and patient contact reminded me that there was a patient at the 
end of a pathology report and some purpose in our work. I soon discovered that 
the best way to learn cytology was to look down the microscope as much as 
possible.  I was an early riser, and I used this to my advantage and managed to 
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get to the lab early and use my own time to study.   
 
There was very little formal teaching at Hammersmith hospital; this was not 
unusual as in the 1980s the training of cytologists was quite variable. These days 
the student must spend a minimum of two years working in the cytology 
laboratory, attend a formal course, and examine a minimum of 5000 slides before 
they can attempt the qualifying exam. In the 1980s it was enough for the head of 
the laboratory to certify a cytologist as competent and many cytologists did not 
bother with examinations. I felt that I needed to prove my competency and 
passed the cervical screening competence examination in nine months.  
 
In 1988 I passed the IBMS Special Examination and became a Fellow of the 
IBMS.  Equipped with this qualification I could now apply for a promotion and 
become a Senior MLSO. I enjoyed working at Hammersmith hospital and if a 
senior position had been available there, I would have been quite happy to stay. 
However a position did not become available and the Head of Cytology 
suggested applying to a newly formed private laboratory, Ravenscourt 
Laboratories.   
 
MOVE TO THE PRIVATE SECTOR 
Private sector pathology in the 1980s was still a new concept in the UK and I was 
advised by many to remain in the NHS, but it was a promotion and my sense of 
adventure took over and I applied for the position.  
 
The interview was not challenging as I had been highly recommended. This 
newly formed laboratory in West London was based at the Royal Masonic 
hospital.  
The workload in my new role was minimal and I used the free time available to 
read books on cytology. The pathologists used to arrive in the afternoon to report 
their diagnostic cases and as the workload was small I could sit with them to 
examine the slides on a teaching microscope. Looking back, I was very lucky to 
have had this opportunity to learn pathology on a one to one basis from such 
good teachers.   
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There were many differences in working practices between the NHS and 
Ravenscourt Laboratories. The main difference was that the pathologists were 
the employees of the laboratory and were accountable to the laboratory director. 
This was in stark contrast to the NHS where, the pathologists effectively ran the 
laboratory and non-medical staff were answerable to them.   I also noted a 
difference in staff behaviour; in the NHS the lab staff took the work for granted, 
but in Ravenscourt they were aware that the client had a choice and could take 
their business elsewhere with resulting loss of revenue and ultimately loss of 
jobs. There was also a sense of teamwork that was noticeable amongst the staff. 
Their motivation was fuelled by the desire to do well and the personal satisfaction 
of a job well-done. Unfortunately in the NHS this element was missing. It is 
difficult to pin point a single reason for this, but staff stagnation and lack of career 
prospects were a real issue in the 1980s’ NHS.  
 
MOVE BACK TO THE NHS 
One negative aspect of working at Ravenscourt Laboratories was the monotony 
of the work. The laboratory did not receive a wide variety of sample types and I 
felt, in time, I would be de-skilled. I discussed this with the medical head of 
department. He felt that I had gained valuable experience working in the private 
sector and encouraged me to apply for a senior post, and try to get back to the 
NHS. I applied for a senior MLSO post at Charing Cross hospital. At the interview 
I was verbally offered the post, but after two months I still had not received the 
written offer which was very disappointing. This was blamed on the inefficiency of 
HR department. Unfortunately this level of delay still occurs in 21st century NHS. 
 
Meanwhile another more senior position (chief MLSO) was advertised at St. 
Peter’s hospital in Chertsey, Surrey. I discussed this move with a few cytology 
colleagues’who all unanimously advised against this move as they thought 
District General hospitals had “backwater” laboratories and I would find the setup 
extremely boring, particularly as I had worked at the Hammersmith hospital. 
 
I was interviewed by two pathologists, an HR representative, and the senior chief 
MLSO. During the interview the more senior pathologist took the lead and 
questioned me extensively on many aspects of cytology. I was honest with my 
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answers and substantiated them with real examples whenever possible. I did 
admit my lack of experience in afew areas, and felt later that I may have over-
emphasised this aspect. I was called by thesenior chief MLSO offering me the 
post. The written confirmation arrived a week later.  I was now the youngest chief 
biomedical scientist in cytology at the age of 25.   
 
St. Peter’s hospital was a District General hospital, a very different organisation 
compared to where I had trained. St. Peter’s was much smaller in size and 
immediately felt friendlier than Hammersmith hospital. The labs were designed in 
a similar way to the Ravenscourt Laboratories, where different pathology 
disciplines branched off from a central corridor. The laboratories at Hammersmith 
hospital were poorly designed with different pathology departments scattered 
throughout the hospital.  
 
The cytology department was quite small compared to today’s standards. It had a 
staff of five people and provided a very small diagnostic cytology service. The 
senior MLSO, who would be my deputy was trained in theUK, but had spent 
many years working in Australia. I was very happy with this as I knew standards 
of cytology were high in Australia and she would be an asset. 
 
During the first year I was busy finding my feet in the new role. I felt secure in the 
job as I felt supported both by technical and medical staff. In the second year I 
decided to introduce some changes to our practice. I discussed my aspirations 
for the department with the Head of Department. I wanted to emulate some of the 
practices that were offered at Hammersmith hospital, such asthe FNA service 
and involvement of biomedical staff in pre-screening of diagnostic cytology.  The 
Head of Department was very forward thinking and agreed to these ideas. The 
FNA service was initially offered to the breast surgeon who ran a clinic to assess 
patients presenting a breast lump once a week. This service was a mirror of the 
service that was offered at the RPMS.  We received very positive comments from 
the surgeon and the Head of Department agreed to open up this service to other 
users. We also started pre-screening the diagnostic work. It felt good that in a 
short time I had been influential in introducing some beneficial service changes.  
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In this chapter I have briefly reflected on my early life in the midst of Iran’s 
revolution which gave me a taste for challenging the status quo. I have described 
how important learning is to me and how I have always used every opportunity to 
develop myself. And finally I have described my introduction to the professional 
world of cytology, and the lasting impression those early years have had on the 
direction my professional career would take, which is the subject of the next 
chapter. 
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CHAPTER 2  FINDING MY PROFESSIONAL VOICE 
OBTAINING A TEACHING POSITION 
It was during 1991 that I felt confident enough to get involved professionally. I 
initially joined the Thames Valley Cytology Society and Southern Cytology 
Society. These informal educational organisations were established by 
enthusiastic cytologists to provide educational activities. I attended a few lectures 
but soon discovered that the educational elements of these meetings were only 
half the story, and most people who attended were interested in networking. The 
concept of networking was new to me. I was told by a colleague that I should talk 
to as many people as possible and try to gather work related information. I found 
this suggestion very unnatural and insincere. I preferred to make genuine, honest 
friendships with people. This approach has served me well over the years. 
Talking to colleagues I discovered that many District General hospitals were 
indeed “backwaters” with many old practices. I saw the cytology societies as an 
opportunity to impart knowledge, but my face was still not known amongst the 
cytology community.   
 
The first opportunity that allowed me to work more closely with cytology societies 
came in 1991 when I was asked to give a talk to the Southern Cytology Society 
on setting up a computer system. (see public presentation 1 Appendix 6) 
 
In August 1992 I saw a small advert in the professional monthly journal IBMS 
Gazette, inviting applications for a part-time lecturing post at Bromley College of 
Technology. The post was to teach on the IBMS Special examination. This was 
the same examination that I had completed four years previously in 1998. I had 
no teaching experience, but I thought that I had a lot of recently acquired 
knowledge that I could pass on. I went to the local library in search of books on 
teaching and presentation techniques. I came away with a few books and read 
extensively to prepare for the interview. I was interviewed by one of the lecturers.  
I told the lecturer that I had no teaching experience, but I was keen to teach.  We 
quickly formed a rapport and he invited me to join the team of four part time 
lecturers.  My commitment in the first year worked out one day a month which 
was manageable. 
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I arrived for my first lecture with amixture of excitement and trepidation. I had 
given a presentation before, but to stand in front of the class for three hours was 
entering uncharted territory. My first lecture was on the respiratory tract, which is 
still one of my favourite subjects. I had decided to cover the syllabus first, but 
exceed it by including further clinical topics which were not strictly required but I 
felt they would make the talk more interesting.   In those days there were no 
feedback or evaluation forms, but I asked one of the students for informal 
feedback at the end of the lecture. It was heartening to hear that she had really 
enjoyed the lecture. I left very happy and energised knowing that I could teach. 
 
BECOMING A REPRESENTATIVE OF THE BRITISH SOCIETY FOR 
CLINICAL CYTOLOGY 
In 1993 I was invited by the Southern Cytology Committee to be the regional 
representative to the British Society for Clinical Cytology (BSCC). The BSCC was 
a medical society established in 1962 to promote the practice of cytology in UK 
by organising scientific meetings. Its governing body was called a council which 
met every three months. The council consisted of 10 medical doctors and two 
token non-medical cytologists. I use the word “token” as it was purely to make 
the society acceptable to non-medical members.  Without non-medical members 
(who were the majority) scientific   meetings were not financially viable.   
 
The role of regional representative was, I felt, not a viable role as the regional 
representatives were not present in the main meeting. Once the main business of 
the Council was finished the regional representatives were invited into the room, 
for a 5 minute feedback.  However, this was not taken seriously by many 
members who would leave during this session. Although I was not satisfied with 
the role, there were many positive aspects including meeting other regional 
members and I continued in the role until 1998.  
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STARTING TO INFLUENCE THE AGENDA OF THE PROFESSION 
In 1994 I joined the committee of the Thames Valley Cytology Society. I was soon 
asked to take up the position of the Meetings Secretary. Although suspicious of 
the motives, I was prepared to undertake this role. The secretary was responsible 
for organising meetings including inviting the speakers, trade sponsors, finding 
the venue, advertising the meetings and sending out the invitations. I felt the 
workload was disproportionally higher than for other committee members, but I 
decided to continue it and organised nine meetings in the four years that I held 
this post.  Even today I still question the motive of colleagues who join 
professional committees but do not contribute to the discussions or running of the 
committee.   
 
The role introduced me to new colleagues. Most importantly, the role gave me an 
opportunity to influence the topics presented. I was keen to involve as many non-
medical cytologists as possible to present lectures. I was quite successful in this, 
as the chair of the society was a pathologist and was happy to leave the 
responsibility to me.   
 
Until 1994 my involvement in the profession was mainly at committee level.  
Although I enjoyed teaching and had the opportunity to put my name forward to 
speak at the Thames Valley Cytology Society, I decided to wait and increase my 
cytological knowledge by attending lectures and reading around the subject.  My 
first formal invitation to present on a purely cytological topic came in the autumn 
of 1994 when I was invited by the chair of the London Histology Discussion 
Group to give an hour lecture on the cytology of head and neck. The venue was 
Guy’s hospital, London, and had attracted 150 biomedical scientists.  (see public 
presentation 2 Appendix 6) 
 
MY FIRST TASTE OF POLITICS AND THE MEDIA 
During the early 1990s there was a series of high profile laboratory errors that put 
cervical cytology under the national spotlight (BBC News 1999, 2001) (the 
Independent 1994, 1998). These errors normally came to light during routine 
audits of the service or occasionally when a woman presented with cervical 
cancer. During a routine audit at St.Peter’s hospital quality issues were 
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discovered with one of the cytology staff. The short audit showed that one of the 
cytologists may have issued too many false negative reports. False negative 
reports occur when a cytologist fails to detect abnormal cells which are present in 
the smear. There could be many causes for this, such as loss of concentration 
when screening, distraction while screening, or poor training.  
 
This was the first time in my career that I felt work related stress. The whole 
department was affected as we knew we had to take drastic action which would 
affect everybody.  There were no guidelines at the time on how to deal with major 
incidents in screening. It was only after 11 major incidents that appeared in the 
national press that the National Health Service Cervical Screening Programme 
(NHSCSP) produced “a guide about how to manage incidents” (NHSCSP 1999). 
Until then there was a varied approach to dealing with these major complex 
incidents.  
 
Once we were certain that there was an issue, the Head of Department and I 
requested an urgent meeting with the hospital board. The Chief Executive was a 
forward thinking individual who made a series of suggestions. We had to take 
some immediate action which included further verification of the errors and 
further recheck of the smears. We were also concerned about the wellbeing of 
the cytologist whose work was under review, as the errors were quite likely to 
make the national news. We arranged for the Human Resources Department to 
offer the cytologist counselling and other support, and set out to review her work.  
 
The reflective exercise took six months to complete and we identified 228 
patients for further testing. Before we could recall a woman for testing, we 
ensured additional clinics were established and also communicated with the 
woman’s GP.  We had expected the hospital to be contacted directly by anxious 
women and so we setup a dedicated helpline operated by trained nurses. A press 
statement was produced that could be provided to the media if required. 
Approximately two weeks after the invitations had been sent out, we heard 
through the hospital press office that the local paper, the Surrey Herald, had got 
hold of the story and it made front page news the following morning. The next 
evening the BBC ran the story on the 6 and the 9 o’clock news. By then many 
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women had already attended for testing. Although we had expected this, seeing 
the name of the hospital mentioned in negative terms was very upsetting. . 
However we were pleased that very few telephone calls were made to our 
dedicated hotline, as communication had been very successful. . Many women 
had already been tested by the time news broke and this had reduced anxiety. 
No woman was harmed as a result of the delayed diagnosis. We felt that we had 
handled the process well and could move on positively from this difficult 
experience. 
 
I believe that due to the measures taken, a very difficult and stressful situation 
had a positive outcome. I took the opportunity to give a presentation on this topic 
to colleagues at Ealing hospital (public presentation 3. Appendix 6) 
 
Cervical screening in the UK started in 1960s without any clinical trials to 
ascertain its risks and benefits. Although a lot of women were screened, there 
was no reduction in death rates from cervical cancer. One of the reasons stated 
by experts was that women at greatest risk were not necessarily being tested 
and the follow up procedures for those being tested positive were insufficient. In 
1988 the Department of Health introduced the systemic call and recall of 
patients. This caused an exponential increase in workload for cytology 
laboratories. This was however not matched by the increase in the number of 
staff and other resources.  Most laboratories had 12 to 14 weeks backlog of 
unreported cervical smears. 
 
To remedy the staffing shortage, the Department of Health brought in the grade 
of Cytology Screener. This grade of staff was employed with basic level of 
general education (typically O-levels) and after a two year training period they 
had to sit a competence examination. This was not a long term satisfactory 
solution as cytology screeners were not remunerated well and there were no 
career prospects, even though they were involved in the very critical job of 
reporting smears as negative. In some ways reporting a sample as “negative” 
should be given the same value as reporting a sample as “abnormal” since a 
false-negative report removes the opportunity to detect and treat a cervical lesion 
for several years. 
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COMPLETING MY MSC 
In 1994 I applied to Imperial College, London, to study for a MSc in Clinical 
Cytotechnology. The course director was the first Professor of Cytology in UK. 
This comprehensive course in cytology covered all aspects of the discipline 
including relevant clinical details. The course director demanded very high 
standards from UK students. I completed the two year part time course in 1996 
with distinction.  
 
The course director was so impressed with my achievements that she invited me 
back to act as an external examiner for the same MSc course from 1997-2000.  It 
was during my visits to Imperial College that the course director suggested that I 
should stand for the council of the British Society for Clinical Cytology (BSCC), 
and she would nominate me.  My previous experience of attending the BSCC 
council as a regional representative was not very good. But as a full member I 
would be present throughout the whole meeting even though I knew I would not 
have a vote as a non-medical member.  I was elected to stand for three years.  
 
Passing the MSc with distinction gave me the confidence to consider expanding 
my diagnostic role. I asked the Head of Department if I could become involved in 
reporting abnormal cervical cytology. Ordinarily only medical doctors reported 
abnormal cervical cytology, however there were rare exceptions. He asked me to 
find out if this practice occurred elsewhere and develop a proposal. I knew of a 
senior colleague in Kent who reported cervical cytology. Although he was a 
biomedical scientist, he referred to himself as clinical scientist. Until 2007 the title 
of clinical scientist was not a protected title and anyone could use it.  He was a 
very experienced scientist and I felt at the time that I could not fully mimic his 
practice. I felt a compromise was necessary and suggested to the Head of 
Department that I should report lower grade abnormality. We jointly prepared a 
supporting case that was presented to the pathology management. This was 
supported and I changed my job title to clinical scientist. In contrast to many of 
my experiences with the medical community, this was extremely positive, as with 
the support of a pathologist I had taken a large step forward, both in my own 
career and for the professional development of my discipline. 
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JOINING THE BSCC COUNCIL AND IBMS SCIENTIFIC ADVISORY PANEL 
At the first meeting, I spent most of the time listening and absorbing. I did wonder 
again after the meeting if it would be worthwhile being a member of this society 
as only one of two non-medical members I would have very little direct influence. 
However I was curious to see how the BSCC operated. There were great 
interpersonal differences and clashes between the council members and 
cytopathologists who were ex-council members. On observation it appeared that 
council members were all jostling for position. It became apparent that they could 
never agree on some fundamental issues. This was very disheartening as all the 
discord and bickering amongst the pathologists would preclude consideration of 
any alternative innovative ideas and prevented the ability to develop.  
 
In 1999 I heard via a colleague that the IBMS had an opening for a member to 
join the cytology Scientific Advisory Panel (SAP). The advisory panels were 
separate from the IBMS main governing body, the IBMS council.  The SAPs 
provided pools of scientific and professional expertise and gave advice to the 
IBMS council in determining policy.  The panels met once every quarter and 
appeared to have a wide role including representing the IBMS on local, external, 
national or Government committees and working parties. 
 
This position sounded very attractive and I applied by submitting my CV and a 
supporting covering letter. I was very pleased to be accepted. I was confident 
that this would give me the platform to propose and undertake change. 
Just after joining the Scientific Advisory Panel (SAP) I was asked to take part in a 
debate at IBMS congress in Birmingham. The debate was with a senior 
biomedical scientist from Antrim, Northern Ireland. The title of this debate was 
“too many qualifications for cytologists” (see public presentation 4 Appendix 6) 
MY LAST BSCC COUNCIL MEETING 
At my last Council meeting I decided to be controversial and asked the chair if 
the BSCC would consider biomedical scientists reporting abnormal cervical 
cytology. This question caused a great commotion amongst the members. I had 
expected this. I also knew that I would be a lone voice on this issue. The other 
non-medical member had adopted a non-confrontational stance and would not 
support me. I was told by the chair that it was only through medical education 
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that the pathologist could interpret the slides and issues the correct clinical 
guidance. I argued that cytology was about pattern recognition. I compared 
cytology to bird watching; one does not need to attend university and obtain a 
degree in ornithology before being able to call a black-and-white bird with a long 
tail, a magpie! I did not mean to offend the group with this statement, which 
sounds derogatory today, but it was a statement from the heart. After a similar 
reply from another council member, I decided to let the matter rest. It was my last 
council meeting and I did not want to leave on a low note. I had tested the water. 
 
In fact I did have some pleasure in hearing that in the year 2000, due to a 
growing shortage of pathologists, the NHSCSP had put pressure on the Royal 
College of Pathologists (RCPath) to develop an expanded scope of practice for 
biomedical scientists. It was indeed the same medical colleague who had openly 
argued with me about the competence of biomedical scientists in reporting 
abnormal cervical cytology who was now charged with developing the new 
qualification. The new qualification called the Advanced Specialist Diploma (ASD) 
in Cervical Cytology was launched in 2001which is still in existence.  
During the same meeting I was nominated by the Council to represent the BSCC 
on a NHSCSP working party to develop a technical quality assurance system for 
assessment of staining.  I was chosen by the council as I had been vocal about 
poor quality and variability of staining across UK at previous BSCC council 
meetings.   
 
OBTAINING THE ADVANCED SPECIALIST DIPLOMA 
The prospect of a new role being developed for biomedical scientists was very 
exciting. We were told that due to the imminent shortage of pathologists, the role 
would be developed within a year. It was difficult to believe the proposed 
timescale as our previous experience with the NHSCSP showed that changes 
generally took much longer than initially planned. The new role was called 
Advanced Biomedical Scientist Practitioner or AP for short. This new role would 
allow biomedical scientists to report all grades of abnormal cervical cytology. A 
new grade with an enhanced payroll was established by the Department of 
Health and details released by a Whitley Council “Advance Letter” (Department 
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of Health 2001). 
 
The NHS asked the professional bodies IBMS and RCPath to jointly develop the 
assessment qualification leading to this post. Interestingly rather than working 
through a committee to develop the qualification, the professional bodies put the 
onus on two individuals; the IBMS Chief Examiner and a representative from the 
RCPath.  This was a wise decision as within six months the examination would 
be available for candidates. 
 
To administer the new exam a new examination board (called the Conjoint 
Examination Board) was established consisting of seven members from the 
IBMS and seven from the RCPath. The chair of the Examination Board was to 
rotate every three years and the RCPath would be holding the chair for the first 
three years.  
 
The initial interest in the examination was from very senior cytologists with 
lengths of service ranging from 20 to 30 years. Many of these colleagues were 
already competent as I had argued at the BSCC council some two years earlier. 
Due to the overwhelming interest in the examination, multiple venues and dates 
were offered.  I applied early and was included in the second sitting of the 
examination and passed. The pass rate was low. In the first year it reached 
approximately 55% but over the years has gradually dropped and is currently 
only 35%.  
 
BECOMING IBMS DEPUTY CHIEF EXAMINER 
The IBMS soon appointed me an examiner and we gradually managed to recruit 
cytology examiners to the Conjoint Board. Due to the increase in workload of the 
Chief Examiner, it was decided to create a new role of Deputy Chief Examiner. 
This was advertised in the IBMS monthly publication the Gazette, and I and three 
other members of SAP applied. The Chief Examiner and chair of the SAP made 
the selection and I was appointed to the post.  
 
This was an extremely positive step forward; biomedical scientists were 
employed to senior roles in a very short time, and biomedical scientists and 
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pathologists worked together to deliver the exam. But this honeymoon period 
suddenly ended – the RCPath issued a guideline to the NHSCSP that an 
Advanced Practitioner (AP) must always be supervised by two pathologists. This 
shocking piece of news came without warning. The Advanced Practitioners who 
were already working in post objected to the IBMS that this statement was 
derogatory, and due to the nature of microscopy the word “supervision” would be 
incorrect as APs would be working and reporting on their own.  It was argued by 
biomedical scientists that no one can supervise another person if they are not 
directly working together. These complaints were ignored.  The IBMS did not 
react to this statement. This was seen by many as a new glass ceiling put in by 
the RCPath to protect their members.  
 
I was asked by the IBMS SAP to give a talk at the IBMS congress in Birmingham 
on the role of Advance Practitioner in Cytology. I agreed to the topic, but asked 
the title to include the words “personal views” as I wanted to remove myself from 
my employer and the IBMS, just in case the talk became controversial.  (see 
appendix 6 public presentation number 5) 
 
TECHNOLOGY AND SCIENTIFIC DEVELOPMENTS STARTING TO SHOW 
THEIR IMPACT ON CYTOLOGY 
The scientific press were very hopeful that a vaccine for cervical cancer could 
soon be developed. It was during this time that I was asked by a committee 
member of Southern Cytology Society to give a presentation to try and predict 
the future. The title for this talk was “Cytology: A dinosaur facing extinction” (see 
appendix 6 public presentation number 6). This was a difficult topic as I was 
predicting the demise of my discipline in not such a distinct future.  This 
presentation was a wake up call for many including myself and prompted the 
IBMS to ask me to expand further on the future, this time giving solutions to the 
workforce on how to deal with changes that technology was going to bring about. 
I was asked to present this at the 2005 IBMS congress. The title of this talk was 
“Career planning for Cytologists” which I presented jointly with the IBMS Chief 
examiner. (Appendix 6 public presentation number 7). This presentation was so 
well received that we were asked to repeat it again in 2006 at Guys hospital for 
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the Southern Cytology Society. 
 
In the same year I was invited by the Scottish Association for Clinical Cytology to 
attend their annual meeting in Perth and talk about the role of biomedical 
scientists in non-gynaecological cytology.  With these talks I was beginning to 
feel that I was influencing the future and could influence the direction that the 
profession should be taking (see appendix 6 public presentation number 8) 
 
BECOMING IBMS CHIEF EXAMINER 
In 2007 I was appointed by the IBMS Council to be the Chief Examiner as the 
incumbent was retiring from the NHS. I was eager to promote the IBMS non-
gynaecological examination.  This was the exam that I was responsible for since I 
became Deputy Chief Examiner. The standard was intentionally kept quite high 
with a pass rate of 60%.  The first opportunity to promote the exam arose a few 
months later when I was invited to the BSCC spring tutorial in Manchester where 
I gave a presentation titled “Biomedical Scientist practitioners in non-
gynaecological cytology: professional qualification, structure, training and 
examination format” (see appendix 6 public presentation number 9). 
 
TAKING OVER THE CHAIR OF RCPATH/IBMS CONJOINT EXAMINATION 
BOARD 
The chair of the RCPath/IBMS Examination Board rotates every three years and 
in 2010 it was the IBMS’s turn, and I became the chair. The Board has seven 
IBMS and seven RCPath members and is supported by an administrator, an 
examination officer, and attended by the Deputy Chief Executive officer of IBMS. 
The Board oversees all matters relating to the two practical examinations, the 
Advanced Specialist Diploma in Cervical Cytology and the Diploma of Expert 
Practice in Non-gynaecological cytology. There are a large body of people 
administrating these two examinations, but when this started in 2001 there was a 
high demand and many sittings were offered. These days the demand has 
decreased and the examination is only offered once a year to maximum of 12 
candidates. 
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I was already an experienced examiner having been involved with the 
examination since 2001 and was fully aware of the politics surrounding them. 
The first chair of the examination had set a very high standard with the pass rate 
which was initially 55%, but over the years it had dropped to 35%. The Advanced 
Specialist Diploma attracted a lot of criticism from within the profession as being 
elitist. I was fully aware that if the pass rate continued to fall I would have to go to 
the IBMS examination board and defend the examination process. When I 
questioned the chair in 2001 about the logic of setting such a high standard, he 
told me that for this role to be accepted there could not be any mistakes and only 
the “cream” of biomedical scientists could rise to the challenge. I accepted this 
thinking at the time, but nine years on I was troubled by the disparity between 
this examination, and the much simpler cytology examination that the 
pathologists had to pass.  
 
The pass rate continued at around 35% and as expected I was asked to talk 
about this at the IBMS Education and Professional Standards Committee. When I 
analysed the pass rate it became clear that the standard set in 2001 was suitable 
for the level of experience of candidates at the time. Almost all of them had over 
20 years practical experience as cytologists, but over time the new candidates 
lacked the depth of knowledge that the initial cohort had. Nevertheless it was 
difficult to defend such a low pass rate for a professional examination.   
 
I was invited by the International Academy of Cytology (IAC) to present a lecture 
at the 2010 17th International Congress of Cytology held at  Edinburgh on 
“Extending the roles in non-gynae-A UK perspective” (see appendix 6, public 
presentation number 10). This lecture allowed me to showcase our non-
gynaecological practice to a very wide audience that included cytologists from 
almost every continent.  
 
NEW CHALLENGES 
Surrey Pathology Service came into existence in April 2011.  This was a merger 
between three pathology departments; Frimley Park hospital, Royal Surrey 
County hospital and Ashford and St. Peter’s hospitals Foundation Trusts. As a 
part of this reorganisation a new post of Specialty Lead was created. This post is 
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normally held by a consultant pathologist, but the person specification was 
written in a manner that a clinical scientist was eligible to apply for it. There was a 
precedent for this; a senior clinical scientist was previously a Head of Department 
in Kent. 
 
I was at a crossroads in my career: I could continue in the current post, but was 
not certain of my future role in a merged Pathology Department, or apply for the 
new role which brought new responsibilities.  I decided to put my name forward 
and applied for the post.  
 
I had to prepare a short presentation.  The panel consisted of the medical 
director, the clinical director and a pathologist from Brighton who was acting as 
an outside observer. The interview lasted over an hour and I left the interview 
feeling that I was unsuccessful, but received a phone call later that day being 
offered the job.  
 
The news quickly circulated around the cytology circles and I heard anecdotally 
that many pathologists in other hospitals were unhappy about my appointment. 
 
The incumbent pathologist who was unsuccessful wrote to RCPath and asked 
them for support. We heard that the RCPath were producing guidelines on who 
should be head of a laboratory. The guidelines were produced a few months 
later. These were very disappointing (see appendix 2).  It was not evidence 
based and had been produced by a group of pathologists for the sole purpose of 
excluding biomedical scientists from laboratory management.  Many biomedical 
scientists expressed their displeasure about this document. 
 
The chair of the IBMS Scientific Advisory Panel, a highly respected biomedical 
scientist from Northern Ireland, and myself discussed our course of action over 
the phone. We felt that our professional body should respond to this document. 
We made an appointment to see the IBMS Chief Executive Officer for a meeting 
at the IBMS headquarters in London. When we arrived we were met by the 
Deputy Chief Executive who informed us that the CEO was not available (we 
later discovered that she was in her office). We would be having the meeting with 
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the Deputy instead. We had already emailed the guidance to the IBMS so we 
knew that they there were fully aware of its contents. We asked that the IBMS 
challenge this and issue its own guidance. The Deputy CEO told us that the 
IBMS had a child-parent relationship with the RCPath. I was very surprised. I told 
her that this may have been the case 50 years ago but we have now surely 
grown up and this must be an adult-adult relationship. The discussion continued 
and became quite heated.  
 
That day I concluded that the IBMS was not a professional body and I did not 
belong to a profession, because of lack of autonomy. 
 
I call this a type of apartheid.  In South Africa apartheid there was a system of 
laws and regulations, the sole purpose of which was to keep Africans in inferior 
position to the whites. So the whites could have a more prosperous life and living 
conditions. The foundation of apartheid was that the whites were superior to 
African, coloureds, and Indians, and the function of it was to entrench white 
supremacy for ever.  
 
The Royal College of Pathologists were now issuing guidelines to keep 
pathologists forever in position of power. Black South Africans had the ANC. 
Biomedical scientists were on their own.  
 
 
 
In this chapter I have reflected on conflicts within committees, the role of 
pathologists verses the biomedical scientists, my role as an examiner, and 
development of a new qualification. I have also reflected on my early attempts to 
influence what I consider is my discipline, cytology. In the next chapter I examine 
my 13 Public Works which, I hope, will support my claim that I have made and 
continue to make a difference within the professional field of cytology. 
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CHAPTER 3 MAKING A DIFFERENCE IN THE 
PROFESSIONAL FIELD OF CYTOLOGY – A REVIEW OF 
MY PUBLIC WORKS 
 
In chapters 1 and 2, I shared my early experiences and how they have influenced 
my values, beliefs and learning in the developing field of cytology.  I now turn to 
the public works I have submitted to substantiate my claim to be at the forefront 
of professional change in this field. There are thirteen publics works in total but in 
reviewing them I discuss them under five headings which reflect five areas where 
I consider I have had greatest influence: 
 
Setting the standards and boundaries of cytology 
Extending the boundaries of cytology 
Extending education to all practitioners 
Leadership 
Improving diagnosis/saving resources 
 
Further details of my public works including sources are in appendix 5 
 
1 SETTING THE STANDARDS AND BOUNDARIES OF CYTOLOGY 
Public work # 1  
External quality assessment scheme for the evaluation of Papanicolaou 
staining in cervical cytology, protocol and standard operating procedures. 
This document describes the process of external quality assurance (EQA) which 
has been influential in improving the quality of staining of cervical samples.  
 
As mentioned previously, cervical screening in the UK started back in 1988 but 
supporting protocols and procedures were produced on an ad hoc basis, often in 
reaction to incidents or issues. Even today some 25 years after the inception of 
the screening programmes, there are still quality issues that have not been 
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addressed. For example there are still no formal agreements or guidelines on 
what constitutes an adequate cervical sample.  
 
The cervical screening process involves removing cells from the cervix and 
staining these before they can be examined under a microscope. The staining 
process for cervical smears is called the Papanicolaou stain after George 
Papanicolaou, who in 1942 devised this method. 
 
Although this staining procedure had been available for approximately 60 years, 
there was great variation in staining quality across the UK. There was anecdotal 
evidence that poor staining may have been a contributory factor in some 
screening errors. For a national screening programme lack of quality control and 
quality assurance at such a fundamental level was problematic. There were 
some quality assurance schemes around the country but they varied in quality 
and were developed by enthusiastic cytologists. 
 
The working party formed in 2000 was made up of 12 members who were tasked 
with writing a document to establish a quality assurance scheme and its 
associated protocols. The meeting was chaired by the chairman of UK National 
External Quality Assurance Scheme. The NHSCSP was also represented as well 
as representatives from the Scottish, Welsh and Northern Irish screening 
programme.  Apart from myself, there were only two other members who had 
laboratory bench experience; one from the National Association of Cytology 
(NAC), who had experience of running a scheme in South West of England, and 
a representative from  the IBMS, who was a laboratory manager. There were also 
two pathologists; one representing the RCPath and the other who had an interest 
in staining quality.  A key member of the group was a statistician from the 
Department of Health.  
 
As there was no previous documentation, we were starting from a zero base. We 
agreed at the beginning that the scheme should address the following points: 
provide guidance on  external assessment of the quality of Papanicolaou staining 
in cervical cytology samples 
establish minimum quality standards for staining 
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maintain and improve quality by achieving consistent good practice 
identify substandard staining quality and the reasons for this and enable remedial 
action 
provide advice and practical help to laboratories 
promote education and training through formal feedback 
achieve recognition through the appropriate accreditationbodies 
 
This was my first experience of working in a large committee under the auspices 
of NHSCSP.  I felt frustrated by the slowness of the whole process. The 
document took four years to produce. We met on numerous occasions in 
Birmingham to go over the same points and, although it was a large group the 
burden of writing the document fell on the biomedical scientists in the group. We 
were passionate about the scheme but differed on how we felt that it should be 
scored. This led to many debates and eventually with the help of the statistician, 
a compromise was reached and a scoring system devised that took the different 
views into consideration.    
 
This was my first major publication and it was rewarding to note that it was 
written solely by biomedical scientists. From a personal perspective I found the 
constraints of working in a committee very challenging. Theoretically the 
synergies of many people working towards the same goal should expedite the 
process but in practice the reverse was true. 
 
This national scheme was to be delivered on a regional basis through the nine 
regional quality assurance teams. My biomedical scientist colleague and I were 
also tasked with providing training for the regional scheme organisers. The 
training initially proved to be a challenge as, although we had written the 
document, the scheme was not piloted, but our assumption about scoring 
stainswas proved correct and the scheme was accepted by the nine regions.  
The aim of the scheme was to introduce consistency of staining amongst UK 
laboratories. There were almost 200 laboratories in 1994 providing cervical 
screening. It can be confidently stated that the scheme has been influential in 
raising and maintaining standards. The scheme has been running for the past 
nine years and has stood the test of time.  
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Personal contribution to the public work: I co-wrote the majority of section on the 
rationale and methodology with another biomedical scientist member and 
contributed to the general discussion. 
 
Public work # 9  
NHS Cervical Screening, National gynaecological cytopathology External 
Quality Assessment (EQA) scheme annual report 
Cervical screening in the UK is highly regulated.  Laboratories have to carry out 
internal quality control and also take part in the mandatory EQA assessment 
scheme. The external scheme in a nutshell involves sending cervical cytology 
slides to a laboratory for reporting. Once all the laboratories have completed the 
slide assessment, the results are analysed and those falling outside the accepted 
range are identified.  The scheme was started in 2003. The full aim of the 
scheme is to:  
provide an external assessment of the quality of reporting of cervical cytology 
samples 
 maintain and improve quality by achieving consistent good practice 
promote education and training through formal feedback 
 identify substandard performance and the reasons for this to enable remedial 
action 
 respond to participant satisfaction and complaints 
 achieve recognition through the appropriate accreditation bodies 
 
The EQA achieves the above aims by an independent system of checking 
participants’ performance through an external agency. This external agency is the 
regional quality assurance office that provides a scheme organiser and an EQA 
facilitator to run the scheme.  The scheme organiser is chair of the Regional EQA 
Committee and is responsible for ensuring that the scheme follows the national 
protocol. The scheme organiser contacts participants when persistent poor 
performance is flagged up by the scheme.  
 
I took over the role of scheme organiser from a senior member of the profession 
who was in this role for 15 years. He had organised the scheme according to the 
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national protocol and I did not feel I could make changes to the running of the 
scheme. However I felt that I could improve the educational element.  The 
scheme provided educational advice through formal feedback on the participants’ 
performance i.e. wait until someone made an error and show them the error. I felt 
this process really was not adequate and I looked for an opportunity to improve 
this.  
 
Part of my role was to write an annual report including detailed analysis of the 
results. The report has a very wide circulation; it is sent to all the participants but 
also many stake holders including hospital chief executives and the director of 
the NHSCSP. The report had to follow the national format, which in my opinion 
was dry and difficult to read. I decided to put my own stamp and on the report by 
including colour images of slides that proved challenging for the participants in 
the EQA.   
 
I received good feedback on the new format. Many participants admitted that 
they had never bothered to read the old report, as it was full of graphs which did 
not make sense to them but were interested in looking at the images for 
educational purposes. 
 
Personal contribution to the public work: co-author  
 
Public work # 10 
Achievable standards, benchmarks for reporting and criteria for evaluating 
cervical cytopathology. 
This was the second time in my career that I was involved in the NHSCSP.  The 
previous experience (public work no 1) was not good, as the last document took 
almost four years to produce. This time however I knew there was some urgency 
as the NHSCSP were about to introduce testing for Human Papilloma Virus 
(HPV) in April 2012. 
 
I was aware that I would be working in a tense working party as three medical 
members of the group would have been involved in writing the document the aim 
of which was to stop a biomedical scientist functioning as head of a laboratory.   
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This document known as ABC (Achievable standards, Benchmark for reporting 
and Criteria for evaluating) had been updated twice before and represents 
probably the most important NHSCSP publication. 
 
The aims of this publication were to: 
revise existing guidelines for reporting cervical samples taking into consideration 
the changes in technology 
 introduce new terminology 
 propose new performance indicators  
 revise guidelines on identifying diagnostic pitfalls which may lead to 
misdiagnosis 
 
The working party consisted of nine members, three pathologists, and two 
biomedical scientists including myself, a gynaecologist, a statistician and two 
executive members from the NHSCSP.   I noted immediately that there was a 
disparity in numbers. Once again the pathologists had managed to gain the 
majority vote. I had come across the other biomedical scientist before and in my 
past experience I knew that she would not be vocal if there were contentious 
issues to discuss.  
 
The work was divided and we agreed to share completed sections by email. The 
first draft was received and I noted terminology referring to a consultant 
biomedical scientist as an advanced practitioner, which was an out of date title 
and now seen by many as a derogatory title. I pointed this out to my biomedical 
scientist colleague and to my surprise she answered “that she was not bothered 
about a name as long she was paid adequately”. I pointed out to her that it was 
our responsibility as biomedical scientists to represent our profession.  
We agreed that she would email the group and request a name change.   
We met on another occasion but the rest of discussions were carried out as a 
teleconference.  This was very unsatisfactory for discussing such a complicated 
document. I felt the NHSCSP were only interested in meeting the deadline of 
April 2012.  In keeping with good NHS tradition the document was published in 
January 2013.The delay in publication received a lot of criticism from colleagues. 
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I fully sympathised with them; the document was rushed through to meet a 
deadline which was not adhered to. 
 
The final review, in my opinion, was very disappointing. It was quite evident that it 
was written by multiple authors. My experience of editing the Cytopathology book 
(Public work # 7)taught me a valuable lesson, that a book written by multiple 
authors should have the same style throughout and this document was far from 
it. The section on statistics was particularly dry.  
 
Another worrying feature of the final draft was the insertion of comments that 
were clearly written to limit the practice of biomedical scientists in cervical 
cytology. I brought these to the attention of the chair. He disagreed with the 
majority of my suggestions, became irritated and told me that he was taking 
chair’s action. 
 
Professionally this is an important document. Although I am very critical of its 
wording regarding the biomedical scientist, nevertheless the document does 
have an important quality agenda. Personally, it was a difficult project to be 
involved with. I was representing my profession and could not stand by and see 
pathologists come out totally in control and dictating the agenda. 
 
Personal contribution to the public work: contributed to writing  and made 
suggestions to ensure biomedical scientists views were fully represented in the 
project.  
2 EXTENDING THE BOUNDARIES OF CYTOLOGY 
 
Public work #5 
Effectiveness of endobronchial ultrasound (EBUS) in obtaining mediastinal 
lymph node samples for immuno-histochemistry at a new district general 
hospital (DGH) service (poster presentation) 
 
Endo-bronchial ultrasound guided bronchoscopy (EBUS) is a relatively new 
procedure used in the diagnosis of lung cancer, infections, and other diseases 
affecting the lymph nodes in the chest.  Since the EBUS does not require 
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invasive surgery, recovery time is greatly reduced, therefore enabling aggressive 
treatment to begin sooner than traditionally prescribed. 
 
The procedure is carried out under local anaesthetic and a mild sedative. 
Although the procedure is safe, it is uncomfortable for the patients and causes 
coughing. Repeat sampling may also cause bleeding and bruising. It is therefore 
important to shorten the procedure as much as possible and limit the number of 
biopsies taken.  On-site cytology examination of the samples under a microscope 
can provide a provisional diagnosis during the EBUS procedure, allowing its 
termination when adequate material is obtained. 
 
This service was introduced at St. Peter’s Hospital following the recruitment of an 
experienced respiratory physician who had experience of this technique. During 
a casual meeting he asked me if I was willing to support him during the 
procedure. We already provided on-site assessment of fine need aspirations 
(FNAs) to clinicians in outpatient clinics, so this was an extension of an existing 
practice. I asked colleagues around the country if this service was provided in 
their hospitals. It appeared that it was only provided in a few centres in UK and 
supported by pathologists (Central Manchester University hospitals 2011). I was 
eager to show that adequately trained and competent scientists could provide 
this service.  I decided from early on that for a service to be sustainable, it had to 
be provided by other biomedical scientists, and asked one of the senior 
biomedical scientists to shadow me.  Initially the senior biomedical scientist was 
providing technical assistance but wassoon offering the on-site assessment. 
 
Over a period of six months we first showed that it was practical to provide on-
site assessment, and also there was a correlation between the rapid assessment 
and the final cytology result.  The next step was to look at the impact on patient 
management. We analysed the results of the first 15 patients and this showed 
that the new EBUS service was highly effective, obtaining diagnostic material for 
further testing, and we could differentiate cancer types accurately. The sensitivity 
was 90%, but more importantly the technique was 100% specific. In many cases 
we had saved the patient from undergoing further more invasive diagnostic tests.   
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The poster was presented at European Respiratory Society (ERS) in Barcelona 
and was well received. It showed that biomedical scientists could safely and 
competently carry out this task. This project gave me the confidence to explore 
other areas where application of simple ideas would be of great value to the 
clinician and the patient.  
 
I promoted our service at every opportunity to biomedical scientist colleagues. 
But I was dismayed to hear that Manchester Cytology training school who were 
organising a training course on EBUS, actively excluded biomedical scientists 
from the course.  This was a very disappointing development, particularly after 
such a close cooperation and positive working relationship with my respiratory 
colleague. 
 
Personal contribution to the public work: provided the cytology data and contributed 
to writing the introduction and the final conclusion. 
 
Public work # 6 
Does immediate cytological analysis at bronchoscopy lead to reduced 
number of biopsies? (poster presentation)  
After our success in establishing an on-site assessment service for the EBUS 
procedure, I discussed the idea of extending this service to routine bronchoscopy 
service with the consultant respiratory physician.  
Bronchoscopy is a safe procedure, but occasionally when taking biopsies, 
bleeding can occur and is desirable to minimise the number of biopsies.  The 
British Thoracic Society guidelines (2001) for diagnostic flexible bronchoscopy in 
adults are currently under review. The guidelines highlight the importance of 
taking five endobronchial biopsies to optimise the diagnostic yield.  We decided 
to investigate if this number of biopsies was really necessary if immediate on-site 
assessment of biopsy was available. Again this is a very simple concept; after the 
biopsy is taken it is placed on the glass slides where a few cells adhere to the 
glass. The cytological preparation is rapidly stained and examined under the 
microscope and immediate feedback is given to the bronchoscopes. 
 
We started the service in March 2010 and reviewed the first 14 patients to see 
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how many biopsies tended to be first pass positive and how many biopsies in 
total were taken per patient. We found that the availability of an on-site cytologist 
within the bronchoscopy room led to a significant reduction in the number of 
biopsies performed without detriment to diagnostic rate or further testing, and 
thus minimising complications.  
 
The poster was presented in 2011 at the Amsterdam European Respiratory 
Society. This simple initiative has had a direct benefit for the patient as it has 
reduced the number of biopsy samples at Ashford and St.Peter’s hospital. We 
have widely publicised this new initiative as we feel it has a real benefit for the 
patient.   We also showed that a biomedical scientist can safely deliver this 
service. I wrote extensively on role of biomedical scientist on assessing sample 
adequacy in the book (Shambayati 2011) that I edited. I also mention this when I 
lecture, as I see the change must come from the ground.  It will take some time 
to bring this practice into routine use across the country but I have received 
enquiries from colleagues on the feasibility and the methodology.  
 
Personal contribution to the public work: provided the cytology data and contributed 
to writing the introduction and the final conclusion. 
 
 
3 EXTENDING EDUCATION TO ALL PRACTITIONERS 
 
Public work # 7 
Cytopathology 
This project took four years to complete and represents my main public work on 
Cytology. 
 
In December 2007 I received a call from the PA to the deputy chief executive of 
the IBMS, who had requested a meeting to discuss a project. When I went to the 
IBMS offices in London I had no idea what to expect. I was told  that they have 
been approached by Oxford University Press (OUP) to collaborate on producing 
a book series on biomedical science, and asked me if I was interested in writing  
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it.  
 
A few weeks later I received a call from the OUP Editor in Chief for Higher 
Education for a meeting in London. I informed him that I had never written a 
textbook before and although I thought I knew my cytology I would need his 
support. He was very reassuring and told me that, except for one author, others 
had no experience of writing a text book either.  
 
At the first meeting he welcomed the group and referred to us as “experts” in our 
fields selected by the IBMS. These nine experts were either IBMS chief 
examiners or university lecturers in biomedical sciences. The editor introduced 
the project and informed the group that there was a gap in the undergraduate 
textbook market. The book series would consist of nine stand alone text books 
covering the following series: 
 
• Biology of disease 
• Immunology 
• Clinical biochemistry 
• Medical microbiology 
• Transfusion science 
• Haematology 
• Cytopathology   
• Histopathology 
• Lab and professional practice 
 
He thought the book would appeal to second and third year undergraduates.  I 
expressed concerns with this approach as over the years the number of 
undergraduate had dropped, as laboratory consolidations were leading to fewer 
trainee positions. I told the group that this would lead to very limited sales. I told 
the editor that there were certainly no new UK textbook in cytology aimed at 
practitioners in the field. I suggested that the book could be aimed at 
undergraduates but also written in a format to be useful to practitioners in the 
field. Writing such a book could be difficult, but I explained that if we explained 
new “jargon” either in the text or alongside the text, the undergraduates should 
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not be overwhelmed by sheer amount of information.   
 
We then discussed the book format. The editor initially showed us a toxicology 
book that he had recently produced. When I thumbed through this book it looked 
old in style and was in black and white, which I thought was not suitable for 
cytology. I expressed my concerns about lack of colour. The editor showed 
another book which was in two colours, the text and figures were in black and 
tables and some artwork in blue. Although the biochemists and immunologists in 
the group were happy with two colours, I still felt that for cytology I needed full 
colour. The editor checked with his production manager and confirmed that the 
book could be produced in colour particularly for a subject such as cytology as 
this is very visual.I spoke to other authors and we all felt that this was a great 
opportunity for biomedical scientists to write a new textbook.  
 
The next task was the subject of authorship. The editor allowed the group to 
decide how we chose to write the book. He said it was easier for OUP to deal 
with a single author, but equally he was open to suggestions from the group. The 
haematology expert in the group was in favour of a multi-author textbook. I said 
that I could write it on my own but I also enjoyed working with other people, and 
probably write the majority of the chapters but invite colleagues to write other 
chapters.  
 
I left the meeting feeling vitalised and hopeful for the future. My next task was to 
provide the OUP with a list of chapter outlines and contributors. 
 
Before I wrote to the OUP I decided to do extensive research. I went to the 
hospital library and requested a dozen recently produced texts in cytology. Many 
of these were American; I noted that the last UK publication that included 
biomedical scientists as authors was Clinical Cytotechnology (Colman and 
Chapman 1989). This book included many pathologists as authors. I was keen to 
produce a book written by biomedical scientists, but the question was whether I 
could select a group of biomedical scientists who had enough experience, but 
also could write coherently to give credibility to the book. 
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This was more of a challenge than I had envisaged. I drew together a provisional 
list of 14 chapters with indicative contents covering the topics that I thought were 
most relevant to current cytology practice in the UK: 
 
• Introduction 
• The cervical screening process  
• Normal cervical cytology  
• Abnormal cervical cytology 
• Management issues in cervical screening  
• Diagnostic cytopathology  
• Lower respiratory tract cytology  
• Urinary tract cytology  
• Serous fluids and peritoneal washings  
• Fine needle aspiration Cytology 
• Andrology  
• Management in cellular pathology 
• Techniques in cytopathology  
• Future trends in cytopathology 
 
The book outline was sent to the OUP who forwarded it to two external 
reviewers. The reviews were favourable. 
 
The next task was selecting the authors. I wrote various names against chapters. 
Although some were high profile colleagues in cytology I had not seen any 
written material by them. I decided to write four of the chapters on my own and 
co-write one with a colleague. The other eight chapters I divided between five 
authors. 
 
After a few days I had completed my list and contacted everyone. I was pleased 
to find that everyone was keen. This was not surprising, since in my experience, 
initial interest did not always produce results.  Once I had their agreement I wrote 
to OUP and provided their contact details so contracts could be issued.   I asked 
OUP to give the authors a deadline of one year for the first draft of their chapter.  
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Once I received confirmation that contracts were issued I wrote to all the authors 
and provided them with overview of the book, chapter contents, style sheet and 
features to include in each chapter. 
 
On reflection I should have done this differently. I should have organised a one 
off meeting with all the authors so we could brainstorm and form ideas. This may 
have speeded up the project by one year and had avoided some of the difficulties 
I encountered with the style later in the project. 
 
I maintained contact with the authors and I set out to write my own chapters so I 
could provide the authors with a completed example.  I started with the chapter 
on urine cytology as I thought this was the easiest. Writing was not easy and it 
took over three months to write 10,000 words. Once I finished the chapter I sent 
it to a colleague   for comments.  He was a technical writer and taught technical 
writing at university. He was very critical of the first draft. He thought it was full of 
jargon as if I had written the text for experts rather than students. I had fallen into 
the trap that I was trying to avoid; hiding behind the jargon to avoid writing and 
explaining the topic. 
 
I sent the chapter with my colleagues comments to the editor. He largely agreed 
with them. This was disappointing. As the editor I could not practice what I 
preached. I decided to go back to a plain piece of paper and start again.  
 
The second draft also took three months to write.  I followed the chapter format, 
fully utilised the key term feature to explain the newly introduced terms, and 
ensured that it was written in conversational style. My colleague received the 
second draft more positively.  This time he only commented on grammatical 
issues.  Once I had made the changes I emailed the editor for his comments.  He 
was happy with the draft and I decided to share this with all the authors. I wanted 
to make sure all the authors had access to each other’s material. For this I used 
the Microsoft SkyDrive and created individual folders for each chapter on the 
web, and gave open access to all the authors.  
 
In 2010 I was ready to submit all the chapters and associated files to OUP so we 
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could go to production. I was told it would take approximately one year to 
produce the book from the time I submitted the files. 
 
My role as the editor had not finished at this stage as I had to answer all queries 
of the copy editor regarding the positioning of the figures and provide any 
missing materials. The last step was to proof read the chapters and make 
corrections before the book went to print.  
 
The book was printed in February 2011. It is difficult to describe the feeling of 
holding the book in my hand. The book culminated probably close to 3 hours of 
work per day for two years which was done in my own time. It made me feel that 
all the personal sacrifices were worth the effort. 
 
Editing and writing this book gave me invaluable experience. Before I started 
writing, I read around the subject extensively.  I read a large number of textbooks 
which greatly improved my knowledge of diagnostic cytology.  I was pleased to 
have learned the art of editing.  As an editor I had to critique other colleagues 
work, add and remove text, and review, whilst remaining very objective.  
 
I thought my work as the editor was completed when the book was finally 
published, but soon I was contacted by OUP as they needed my input to develop 
an online resource for the book. I was concerned about having to do more work 
on this project so soon after publication, but when I was approached by a 
colleague from London Metropolitan University I felt it difficult to turn down his 
offer of collaboration. 
 
The online resource was mainly aimed at undergraduates who had no 
experience of laboratory environment to help them better grasp the subject. It 
comprised:  
 
• an interactive digital microscope with case studies to further 
demonstrate points made in the chapter 
• video interviews with practising biomedical scientists  
• Interview with a consultant clinical cytologist 
• Interview with a biomedical scientist 
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• videos of key practical techniques to introduce the student to the 
practical aspects of cytology 
• processing a bloody sample 
• processing a urine sample 
• processing a cytology sample 
 
http://global.oup.com/uk/orc/biosciences/biomed/shambayati/ 
 
 
Once we agreed to the content, we met on a number of occasions to complete 
the work. I was fortunate that one of our recently qualified biomedical scientists 
was willing to help us with technical videos. 
 
The book was welcomed by biomedical scientists.  It has been an Amazon.co.uk 
bestseller in the cytology section on a number of occasions.  See below for 
academic reviews and appendix 7 for some of Amazon.co.uk reviews.  The 
response from pathologists has been somewhat muted. I heard indirectly that 
colleagues had heard a pathologist commented that “he could not believe the 
quality of the book”.  
 
For me the greatest pleasure is seeing the book in use. Pictures below were 
taken a week apart in April 2013; the first picture shows undergraduate students 
using the book during a practical session. The second picture was taken a week 
later at a cytology course at the East Pennine Cytology Training school and 
shows practitioners in cytology using the book.  
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Cytopathology reviews 
 
Academic reviews 
 
Clearly written, factual and concise 
Dr Patricia Gadsdon, School of Biological Sciences, 
Bangor University. 
 
The flow of information is excellent and the text is 
well written… a good introductory text for undergraduate 
with an interest in cytology and for professionals in 
training.  
Dr Lesley Walton, School of Bimolecular Science, 
Liverpool John Moores University  
 
Lucid, logical coverage of material, set out 
thoughtfully and supported by good illustrations and 
learning features that make the text student-friendly... 
a very useful undergraduate cytopathology textbook.- Dr 
Nicholas Vardaxis, Endeavour College of Natural Health 
 
I would definitely recommend this book to anyone." - 
Jermin Simon, student, DeMontfort University 
 
Please see appendix 7 for some of Amazon.co.uk reviews. 
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Personal contribution to the public work: Involved from the inception of this project. 
Wrote four chapters, co-wrote a chapter and edited all the chapters. 
 
Public work # 8  
 
Self assessment in lower respiratory tract cytology  
 
Diagnostic Histopathology is a review journal aimed at practising diagnostic 
pathologists and trainee pathologists with invited reviews on histopathology and 
cytology.   
 
I was invited by a consultant cytopathology at Royal Liverpool hospital to write 
this educational self-assessment on respiratory cytology. I felt this was a very 
positive gesture that a consultant pathologist had recognised my knowledge of 
the subject and had put my name forward to write for a medical journal. As far as 
I know this is the first educational article written by a non-medical cytologist in 
this journal. 
 
I produced three case studies for the self-assessment. The answers to the case 
studies were revealed at the end of the article. The format that I followed was 
very similar to the case studies that I had written only a short time ago for the 
OUP Cytopathology textbook. The level of detail was also very similar. I was 
interested to find out if the editor of the journal would ask me to vary the format, 
but I was told that the article was accepted without any changes.  
I received a one year subscription to the journal, which contributed to my 
continuing professional development. 
 
Personal contribution to the public work: author 
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Public work #13 
Scientific Training Programme learning guide in cytopathology  
I was invited in 2012 to co-author the cytopathology section of the learning 
guides for the newly developed Modernising Scientific Careers (MSC). 
 
MSC is a UK wide government initiative led by the UK Chief Scientific Officer to 
address the training and education of healthcare scientists in the NHS. The idea 
is to standardise training for 50,000 plus healthcare scientist in UK.  The process 
began in 2008. The final policy document was published in February 2010 in the 
document Modernising Scientific Careers: “The UK way forward” (Department of 
Health 2010). 
 
The document outlined the goals of the MSC: 
 
• meet future service needs by ensuring scientific and technological advances 
are incorporated into emerging models of integrated care 
• provide an improved approach to workforce planning and development of an 
appropriate skill mix  
• bring the education and training of the healthcare science workforce more into 
line with that of other healthcare professionals;  
• create clear career pathways and education and training programmes in a 
common framework for the whole of the scientific workforce 
• ensure the focus in education and training programmes is on training and 
enhancing the training experience rather than on trainees being required to 
deliver service 
• include greater flexibility in skill and knowledge development in initial training, 
rather than an emphasis on extensive uni-disciplinary experience 
•  
The proposal had overall broad support. However it had a very tepid response 
from the IBMS who felt that the MSC will ultimately damage its membership 
base. In 2010 the IBMS issued a statement (IBMS 2010) stating its concerns 
over the structure of the MSC project for biomedical scientists. It felt that 
biomedical scientists belonged to a mature regulated profession with a defined 
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educational pathway that produced individuals fit for purpose. The IBMS felt that 
the MSC would lead to service destabilisation if the IBMS career structure is 
dismantled. 
 
This was quite typical of what had occurred over the years from the IBMS, being 
reactive rather than being proactive and trying to shape the future. The IBMS 
Chief Executive at the time told me that the MSC would fail and we should not 
worry about it.  The main concern of the IBMS was that the new structure did not 
take into account any of the established IBMS examination pathways, including 
the IBMS accredited degrees. The new structure included four career levels as 
outlined below:  
 
• Associate /Assistant 
The grade would be similar to the current Medical Laboratory Assistant (MLA) 
grade, but would include formal training. Assistants and associates would be 
supervised and undertake task based roles. The associates would undertake 
more complex laboratory tasks. 
• Practitioner Training Programme (PTP) – undergraduate level 
This 3 year BSc (Hons) integrates academic and workplace based elements. 
This would be equivalent to the current basic grade and specialist grade 
biomedical scientist grade. It would allow progression to the scientist training 
programme. 
• Scientist Training Programme (STP) – postgraduate entry, pre-registration 
training 
This 3 year workplace-based programme would require part time attendance at a 
university to obtain an MSc. This grade would be equivalent to the current clinical 
scientist grade. 
• Higher Specialist Scientific Training (HSST) – doctorate level 
This is a 4/5 year work based training programme similar to the medical 
consultant training, leading to medical college examinations where these exist, 
and a doctoral award. This grade currently does not formally exist in the UK. 
 
I saw the MSC as a great opportunity for the biomedical scientist profession to 
progress and possibly develop into a new profession. I was however under no 
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illusion that the HSST would not be supported by the RCPath and they saw this 
grade of staff as a direct challenge to their own profession.  
 
In September 2012 I received a personal invitation from the chair for the Cellular 
Science Board, to join the National School of Healthcare Science (NSHCS) to 
represent the NHS South.  The NSHCS was setup as part of the MSC 
programme to oversee the delivering of the training, overseeing a national 
system of assessment and general co-ordination of the training programmes. 
 
The NSHCS could be described as a virtual school as all the assessments are 
carried out online. The assessments take many different forms but all are 
recorded on an Online Learning and Assessment Tool. This allows the school to 
monitor the progress of the trainees. 
 
I was asked by the Head of School to co-author the cytopathology section of the 
learning guides, I saw this as an opportunity to shape the future. I discussed our 
approach with a colleague who had agreed to co-author the section. I told him 
that I believed this was a unique opportunity and we must push the boundaries to 
show that a STP trainee is clearly different to a biomedical scientist.  We both 
agreed that there was more scope in the diagnostic cytology section of the 
learning guide, as cervical cytology was heavily regulated and we may encounter 
resistance from the NHSCSP.  
 
I had previously worked with this colleague as he was one of the authors of the 
OUP Cytopathology book.  I was familiar with his strengths and weakness and 
was confident that we could complete the task as soon as possible. Our work 
was accepted without any editing. 
 
It is too early to say if this piece of work has had the desired impact, as the 
trainees are still in the process of completing their training. The first cohort will 
finish in 2014 and this would be the ideal opportunity to receive feedback from 
employers, training officers and trainees. 
 
Personal contribution to the public work: wrote the diagnostic cytology sectionof the 
guide and contributed to the section on cervical cytology 
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Public work # 2 
Institute of Biomedical Science (IBMS) record of laboratory training for the 
Specialist Diploma in Cytopathology.  
 
I was invited in 2005 by the IBMS Chief Examiner, to co-author this document.  
She was an experienced cytologist, but had not practiced cytology for some time 
as her career path had taken her away from the microscope to quality assurance. 
Her past experience was also limited to the field of cervical cytology therefore my 
expertise in diagnostic cytology was required.  
 
The IBMS specialist diplomas are aimed at newly qualified biomedical scientists 
who develop a portfolio to evidence their training, practical skills and their 
competency in the first two years after registration. Prior to the creation of this 
document there was no other means of assessing or proving competency of 
newly qualified biomedical scientists. Many employers have since used this 
benchmark when considering promotion to the grade of specialist biomedical 
scientist.  The attainment of Specialist Portfolio permits the newly qualified 
biomedical scientist to progress up the membership class and become a 
member. The relationship of Specialist Portfolio to other IBMS qualification 
structure is shown in the table below: 
 
Examination Membership class Notes 
Higher Specialist Diploma Fellow Five years of professional 
experience and attainment 
of Higher Specialist Diploma
Specialist Diploma Member  After two years experience  
and attainment of Specialist 
Diploma 
BSc (Hons) and attainment 
of certificate of competence 
to enable registration 
Licentiate Entry to the profession 
Whilst studying for a BSc Student  
Our remit was to write the portfolio so the following learning points could be 
demonstrated by a newly qualified biomedical scientist: 
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• knowledge  of complex scientific and technical aspects of their  discipline 
• procedures for handling specimens before, during and after analysis 
• maintenance of  routine equipment 
• manipulation of  simple data 
• awareness of quality control/assurance procedures 
• knowledge of the scientific basis of the laboratory tests and the disease 
process under investigation 
 
This was my first piece of work for the IBMS as the Deputy Chief Examiner. I was 
keen to make a positive impact. Due to variation in laboratory practice in UK, it 
was difficult to write a specialist portfolio to encompass all the tasks. I decided to 
focus on a range of work performed by most routine laboratories in UK, and 
included tasks such as diagnostic cytology to give a strong message to 
employers that they needed to provide training and development for their staff. I 
purposely included elements of works such as screening of diagnostic cytology 
samples that in many hospitals was only carried out by pathologists.  
 
The portfolio has been updated twice and is now in the third edition. 
Consolidation of laboratories, which has occurred in the past three years, will 
most likely change the nature of future cytology laboratories, and a specialist 
portfolio may need to be rewritten completely to consider these changes. 
 
I asked for verbal feedback from post registration biomedical scientists who have 
completed the portfolio. They all felt that the portfolio gave them a clear direction 
for training. It also helped the training officers in the department to design a 
training package. The feedback on the format was generally positive, especially 
the reflective reviews at the end of each section. The completion of the portfolio 
has given confidence to many to continue with in-service education and pursue 
the IBMS Higher Specialist Diploma. The major criticism was that it was too time 
consuming, particularly in the new NHS where limited time is available for in-
service education. 
 
Personal contribution to the public work: wrote the diagnostic cytology section of the 
guide and contributed to the section on cervical cytology 
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4 LEADERSHIP 
 
Public work # 4 
Using Lean to lead change (poster presentation) 
In 2009 I saw an advert for a Department of Health sponsored leadership 
programme titled “Influencing the future-a leadership programme for senior 
scientists”. This was delivered by Phoenix Consultancy, a leadership and 
development consultancy based in the US. I applied for the programme and was 
interviewed by the president. She said that they were looking for people who 
were willing to make changes to the health service. I was asked if I could commit 
to their schedule as attendance at the whole programme including the five 
residential days was mandatory. It was also mandatory to take part in a service 
improvement project. I confirmed my commitment and also agreed to a project. I 
was accepted on the programme.  
 
My project was to test if “Lean” methodology could be used to bring in culture 
change. Lean is used extensively in the NHS.  Lean is an improvement approach 
to facilitate work flow and eliminate waste. It was initially developed by car 
manufacturer Toyota. Lean is about minimising waste. For it to be successful 
participants need to be flexible and open to change. I wanted to explore if the 
concept could be used to be applied not just to improving the process but also to 
improve staff morale.  
 
I read extensively around the subject of staff motivation. There were theories that 
suggested staff involvement in projects contributed to increase in their 
motivation.  
 
In 2008 I applied for the laboratory to take part in a project sponsored by the 
NHS Improvement. The NHS Improvement was one of many NHS quangos 
(quasi-autonomous national governmental organisations) that was axed by the 
Health Secretary in 2010 to save money.  Prior to its closure it worked with ten 
cytology laboratories to improve the turnaround time of cervical smear results. 
The project was called “achieving a 14 day turnaround time in cytology”. The 
background to this project was the 2006 Review of Pathology Services in 
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England by Lord Carter (Department of Health 2006). He recognised Lean as the 
method of choice for improving processes in pathology services.  
 
I was chosen as the local clinical lead and asked to bring together a multi-
disciplinary team of all parties involved in cervical screening to work together 
collaboratively. These included colleagues from the primary care agency who 
wrote to the patient with the invitation letter and results, the practice nurse taking 
the smear, and the laboratory staff. I purposely included many relatively junior 
laboratory staff in the project as I wanted their involvement in ideas to change 
practice. I noted that other clinical leads had chosen higher numbers of senior 
staff in their teams.  
 
The project involved attending three residential workshops where we were 
trained on Lean methodology. I noted that there was some overlap between the 
Lean and leadership principles in terms of involving staff in the decision making: 
 
Some leadership principles (Kouzes and Posner 2008): 
• Challenge the system (openly challenge the status quo, experiment and take 
risks) 
• Inspire shared vision (values and beliefs) 
• Align constituencies (involve outsiders, informal structure, encourage goals) 
• Encourage the heart (trust others to act, encourage experiments, celebrate   
achievements) 
 
Some Lean principles (Liker 2004): 
• Empower staff to make changes 
• Daily meeting to problem solve 
• Visual management to aid communication 
• Information/data to support the process 
•  
The aim of the project was to improve turnaround time of smears, but I was keen 
to see if staff morale could be improved by their involvement in a project which 
promised to bring tangible changes to turnaround times of cytology results. 
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To access the impact of the project on the team morale, a short survey was 
designed. A simple rating scale of 1 to 5 was used (1=strongly disagree, 
2=disagree, 3=neither agree nor disagree, 4=agree and 5= strongly agree). The 
table below shows the result of the survey which was given to staff at the 
beginning of the project and the same survey repeated towards the end. 
Although the survey results was not scientifically analysed it showed a modest 
improvement in some of the responses, and considerable improvement to the 
question asking aboutmorale.  
 
Survey Questions October 2008 July 2009 
I am clear what my duties and responsibilities are 4.2 4.3 
I can cope with my workload and what is expected 
of me 
3.9 4.4 
I have everything I need to do my job 3.7 4.2 
My work is interesting 4.1 4.2 
I get help and support I need from colleagues 2.9 3.4 
My opinions really seem to count with my 
manager and colleagues 
2.9 3.4 
There are opportunities to learn and develop 3.9 3.8 
I am listened to   2.9 3.6 
I feel valued 2.8 3.4 
I am empowered to make changes in my work 
environment 
2.8 3.4 
I feel valued 2.8 3.4 
I am empowered to make changes in my work 
environment 
2.8 3.4 
I am consulted and I know what is going on 2.8 3.4 
Since the project started in my morale improved      
Yes               
   No                                                                          
     12.5%`      
      87.5%                                           
63% 
37%
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Our team redesigned the service and delivered significant improvement in 
productivity. We cut out waste from the process whenever possible, and 
comparison of data in March 2010 showed that we provided the fastest 
turnaround of smear results amongst the ten laboratories in South East Coast 
region.  
 
The whole team learned a lot from this project. It noticeably boosted 
interpersonal relationships amongst team members. The effect of the project was 
long lasting and team members took pride in telling colleagues from other 
laboratories about their achievements.   
 
I presented my poster at the graduation meeting of the NHS leadership 
programme “Influencing the Future” in July 2010 and was awarded the prize for 
best presentation 
 
The project helped me to further to develop my leadership style. I felt that a 
democratic leadership style was effective in that scenario. 
 
Personal contribution to the public work: author  
 
5 IMPROVING DIAGNOSIS AND SAVING RESOURCES 
 
Public work # 3 
Collection fluid helps preservation in voided urine cytology 
This paper following on from a MSc project that I supervised was published in a 
peer review journal, has a quality theme. I was keen to improve the quality of 
urine cytology samples. 
 
A urine sample is one of the commonest sample types received in cytology 
laboratories.  It is often used for diagnosis of bladder cancer, but it may also 
detect kidney cancer and cancer of the ureter. If abnormal or cancerous cells are 
detected most patients undergo a cystoscopy (fibre optic tube with a camera for 
examination of urinary tract).  
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The Achilles heel of cytology is an “unsatisfactory” or an “inadequate” cytology 
report. In these cases a result cannot be issued and the test has to be repeated. 
Unsatisfactory samples in urine cytology are common. In a recent publication 
2.3% of samples were classed as inadequate (Mishriki SF et al 2013). This is 
usually due to the nature of the chemicals present in the urine.  Degeneration 
and contamination can lead to false negatives and false positives in diagnosis, 
and so their prevention should improve cytological assessment. This fact has 
been known for many years but the cytology community are generally slow to 
take action to remedy issues. I was aware of this problem when I started my 
career in cytology and now some 21 years later we are still receiving unfixed 
urine samples (unfixed means without a preservative solution to slow down cell 
breakdown).  
 
The opportunity to make a positive change came when I was asked by one of my 
cytology colleagues, who was studying for an MSc, to suggest and supervise her 
project.  
 
Generally funding for MSc projects in the NHS is very low and supervisors 
struggle to develop a project that would satisfy the university regulations and can 
be funded from the pathology budget. The project I had in mind was to 
scientifically assess the effect of a variety of commercially available fixatives 
(preservative) on the market. There was anecdotal evidence that these worked, 
but to change practice I felt an evidence based approach was more effective.  
 
I discussed the issue of inadequate urine results with one of my consultant 
urologist colleagues. He also agreed that an inadequate report was a waste of 
resources and we needed to reduce the numbers if possible.  My colleague 
agreed to discuss this with three other colleagues who used our service. This 
also involved communication with at least seven urology nurses who were in 
charge of obtaining urine samples.  To reduce the cost we asked the 
manufactures to sponsor the project by donating pots of their fixatives, but told 
them this would be the limit of their involvement. 
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Once all parties agreed to take part we provided the clinics with four different 
pots.  One pot was empty to mimic the routine practice, and three contained 
fixative collection fluid. The urine sample was divided by the nurses once the 
patient had produced the urine. The pots were sent to the laboratory and 
processed in the same way. The slides were assessed for the level of 
degeneration by two biomedical scientists in a blind trial (without knowing the 
type of collection fluid used for each slide). Ten cellular features were chosen for 
assessment and these were tabulated. We discussed our project with a 
statistician who suggested a ranking system for each patient’s sample. The 
scores for each sample were ranked and these values were compared against 
one another using Friedman’s test (a statistical test for comparing sample 
characteristics). 
 
The statistics showed a significant diagnostic difference between the routine 
method and the three collection fluids. This meant that the preservation had been 
effective.  No significant difference between the three collection fluids was found 
as all three preserved equally well.  
 
We discussed our findings with the users and we all agreed use of fixative to 
collect urine samples. To facilitate this we asked a manufacturer to prepare 
adequately labelled pots and distributed this to the users.  
 
As this would benefit all cytology labs, we decided to promote our findings. In 
September 2009 the first author presented this paper at the bi-annual IBMS 
meeting in Birmingham. The message was clear; that the use of fixative would 
reduce the number of inadequate samples, inconvenience for the patients, and in 
delay in diagnosis. The other important message was that fixatives increased the 
sensitivity of the urine test. 
 
This was an innovative project with a very low set up cost which has benefited 
the patients, the requesting doctors and the laboratory. Personally I learned a 
great deal from this small project. It was my first experience of supervising a MSc 
project.  I learned that for a successful MSc project it must have a well-defined 
goal that is realistic given the time available to the students. I have since 
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supervised two other projects and applied the learning. 
 
Personal contribution to the public work: Initiated the project and provided 
supervision throughout. Contributed to the introduction and the conclusion. 
 
 
Public work #11“Mesothelioma diagnosis in a district general hospital” 
(poster presentation) 
Public work #12“Retrospective audit of malignant mesothelioma diagnosis in 
a District General Hospital” (poster presentation) 
The public works 11 and 12 are very similar in theme; therefore I will discuss them 
together. 
Malignant mesothelioma is a rare cancer affecting cells of the mesothelium, the 
cells which cover many internal organs of the body. Diagnosis can be suspected 
from radiological appearance but must be confirmed either by examining serous 
effusion cytology (fluid accumulated around the lungs) or with a biopsy (removing 
a small piece of tissue for histological diagnosis). Sometimes a thoracoscopy 
(endoscopy procedure to examine the pleura and take larger biopsies) is needed. 
 
Cytology is the least invasive method of obtaining a diagnosis, but sometimes 
cellular features can quite subtle and differentiating cancer cells from normal cells 
is not possible.  We have noticed this many times when diagnosis of 
mesothelioma is confirmed by other means such as a biopsy, and when we 
retrospectively examine the cytological slides. 
 
The problem with a rare disease such as mesothelioma is that cytologists tends 
to lose diagnostic competence, as they may only come across this condition 
once a month or so.  To avoid this I made extra cytological preparations and 
examine these periodically to remind myself of the cytological changes. This 
proved to be a very useful tool, and I still use this method to maintain 
competence. 
 
I had anecdotal evidence that we had improved our cytological diagnosis. To 
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prove this we analysed the effectiveness of various diagnostic modalities 
including pleural fluid cytology, ultrasound guided biopsy and thoracoscopically 
guided pleural biopsy between 2007 and 2011.  
 
There were 55 patients in our study period that were diagnosed with malignant 
mesothelioma. Of the 33 patients that had fluid examined by cytology 17 (51%) 
had the disease diagnosed via cytology. Other patients were diagnosed using 
combination of biopsy or biopsies obtained via thoracoscopy.   However it was 
interesting to note that that cytological diagnosis had improved year by year from 
2007. In 2007 just over 20% were diagnosed by cytology, this figure rose to 38% 
in 2008, 42% in 2009, 58% in 2010, and 80% in 2011.  The study numbers are 
probably too small to be scientifically significant, but it confirms our anecdotal 
evidence that our cytology diagnosis had improved by applying newly learned 
techniques. 
 
Service improvement has motivated me over the years to improve the cytology 
service at Ashford and St.Peter’s hospitals. This project showed that we had 
indeed improved our diagnosis of malignant mesothelioma and thusavoid the 
need for the majority of patients to undergo more invasive testing. 
 
The result of this study was presented as posters and presented at two scientific 
conferences and from the questions asked during the presentation it showed 
there was genuine interest from the participants in the result of our study. 
 
Personal contribution to the public work: provided the cytology data and contributed 
to the writing the introduction and the final conclusion. 
 
 
This completes my review of my public works to support my claim of making a 
difference in my profession.  In the final two chapters I reflect on what it means to 
be a professional, how cytology measures up as a profession and how what I 
have learned through this account has changed me and my profession 
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CHAPTER 4   WHY IS BIOMEDICAL SCIENCE A 
PROFESSION AND HOW HAVE I HELPED IT BECOME 
ONE 
DO BIOMEDICAL SCIENTISTS CONSTITUTE MEMBERS OF A 
PROFESSION? 
According to Lester (2010) “Profession derives from the Latin word ‘profiteor,’ to 
profess, which can also have the connotation of making a formal commitment in 
the sense of taking a monastic oath. This root might suggest that a professional 
is someone who claims to possess knowledge of something and has a 
commitment to a particular code or set of values, both of which are fairly well-
accepted characteristics of professions”. 
 
As Lester suggests, knowledge and a code of values are attributes of a 
profession.Brante (2011) also considers knowledge is a necessary attribute but 
believes it is not a sufficient condition. Freidson (1988) believes autonomy  is a 
defining attribute. He also suggests that occupations organised around medicine 
which are ultimately controlled by a doctor have a “paramedical status” or 
supporting role, and it is only the  doctors who  have full autonomy in their 
practice. 
 
I will consider the following attributes authors have used to define a profession: 
autonomy, knowledge and training, continual professional development, having a 
professional body and a code of practice.  
 
AUTONOMY 
Autonomy is derived from the Greek words ‘autos’ and ‘nomos’ meaning self and 
to rule. The Oxford Dictionary of English defines autonomy as the right or 
condition of self government and freedom from external control or influence.   
 
Biomedical scientists in the early 1900s had a supporting role to the pathologist 
and originally they could only work under the direction of a pathologist. They had 
very little autonomy. But gradually over the years and mostly since the 1980s as  
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laboratory techniques expanded, they started taking some degree of 
responsibility for carrying out the tests.  However it was not until 2001 that a 
biomedical scientist in cytology could claim autonomy in practice when they could 
report on all aspects of cervical cytology.   
 
The argument that medical doctors have full autonomy in their practice no longer 
holds true. In the NHS, doctors are subject to control, regulation, and increased 
accountability by the hospital management.  Even when treating patients they 
have to follow guidelines issued by various regulatory bodies. They can no longer 
make decisions on their own and have to follow an agreed treatment plan.  
 
As can be seen professional autonomy which was once considered an essential 
attribute of a profession in my opinion is no longer valid, as employment and 
organisation constraints have largely removed it. In this respect biomedical 
scientists in cytology are no different. 
 
KNOWLEDGE AND TRAINING 
Brante (2011) considers specialist knowledge is a necessary but not a sufficient 
condition for defining a profession. It derives from training and experience.  
 
Biomedical scientist have strict entry criteria and undergo years of training. The 
entry route to the profession is via obtaining an IBMS accredited undergraduate 
honours degree in biomedical sciences. In addition to meeting this entry criterion 
the candidates must undergo a period of laboratory training (usually 12 months) 
and complete the IBMS registration portfolio.  
 
This is considered to be the entry point to the profession and the biomedical 
scientist can register as a licentiate.  At this point the licentiate can start to work 
towards obtaining the IBMS specialist diplomas which normally takes a minimum 
of two years. The next membership class is the class of the member.  The 
members have the opportunity to study and prepare towards the IBMS higher 
specialist diploma. Obtaining this qualification after at least three years of 
professional experience allows the member to register as afellow. After seven 
years post registration experience fellows have access to the IBMS advanced 
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specialist diploma in cervical cytology that allows practice at the highest level..  
 
 
CONTINUING PROFESSIONAL DEVELOPMENT (CDP) 
Knowledge also comes from continuous professional development (CPD). CPD 
is lifelong learning that allows the professional to maintain their knowledge and 
skills, and keep pace with the new developments in their field.  CPD may include 
'formal' activities such as attending courses, conferences and workshops, as well 
as self-directed activities including writing essays, directed reading and reflective 
practice.  Although CPD may be voluntary in many professions, it is a mandatory 
requirement for biomedical scientists to maintain their registration with HCPC. 
 
PROFESSIONAL BODYAND CODE OF PRACTICE 
Membership of a professional body is considered one of the attributes that 
characterise a profession. Most professionals belong to a professional body 
which seeks to further the particular interest of the profession and regulate it.  
 
Biomedical scientists belong to a well established professional body, the IBMS.  
One of the aims of IBMS is the development of biomedical sciences and 
maintenance of professional standard of practice for patient care and safety 
(IBMS 2011). The IBMS has evolved over the years. The timeline below shows 
some key dates in this evolutionary journey:  
 
Pathological and Bacteriological Laboratory Assistants Association (PBLAA)1912 
Institute of Medical Laboratory Technology (IMLT)    1942 
Institute of Medical Laboratory Sciences (IMLS)    1975 
Institute of Biomedical Sciences (IBMS)      1993 
 
It started in 1912 as an association for the laboratory assistants (PBLAA).  This 
association could not be described as a professional body as it had a very basic 
examination and membership structure. By 1942, the IMLT was formed. The 
IMLT redesigned the membership grades, produced new examinations and 
established an exam board to deliver the new examinations. In my opinion the 
IMLT still fell short of full professional body status as the examinations were still 
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administered by pathologists and not its own members. 
 
 In 1975 with the increase in scientific element of the work, the IMLT changed its 
name to the IMLS.  It also saw the first appointment of a non-medical person as 
its president. The examinations were now administered by senior members of the 
profession and the early shoots of an emerging professional body could be seen. 
Advances in the science and the changing role of biomedical scientists 
necessitated a further name change in 1993 to the IBMS.  By this time it had 
matured to a professional body with committee structures working with its 
governing body to deliver the professional agenda.   
 
The IBMS code of practice (IBMS 2011) is written specifically for biomedical 
scientists and sets out the ethical standards that a biomedical scientist must 
adhere to. Biomedical scientists are required to fulfil their professional role with 
integrity, refrain from misuse to the detriment of the patients, and take steps to 
safeguard patients and others.  
 
CONCLUSION 
Knowledge is a necessary but not a sufficient attribute of a profession. Other 
attributes such as a code of practice, membership of a professional body and 
CPD are also required. Biomedical scientists do not have complete autonomy, 
but this is not a defining attribute. Therefore in my opinion the occupation 
satisfies the necessary attributes to make it a profession. 
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MY PROFESSIONAL VALUES 
In the next section I will describe how my actions and values have contributed to 
developing the profession of biomedical science. 
 
CHALLENGE THE SYSTEM –ASK QUESTIONS 
Living through and experiencing the 1979 Iranian revolution in my teenage years 
had a deep effect on my personality and instilled the habit of asking questions 
and challenging the existing mindset.  Traditionally the biomedical sciences have 
been regarded as a technical subject; however due to the evolution in laboratory 
methodology and science, in my opinion, the focus should be more clinical. This 
is demonstrated through procedures and practices accomplished by myself and 
our team at the cytology department at Ashford and St.Peter’s hospitals where I 
have encouraged my team ro take broader roles. This has resulted in 
improvements and a more flexible delivery of the service, reducing waiting time 
for test results for direct benefit of the patients. Public work number 4 describes 
such an example when challenging the existing work practises resulted in 
improvement to cervical cytology services. 
 
PERSONAL RESPONSIBILITY 
I have always believed that I must take personal responsibility for my own 
actions. Although it is not possible to control every situation in life, taking 
personal responsibility allows one to create a path ahead, and shape the future.  
As an example: during my tenure as the IBMS chief examiner I have been 
criticised for setting a high standard in the examinations when there were 
occasions when examination pass-rates were low.  I have always stood by my 
decision of keeping the standards high, as I believe it is through increasing 
knowledge that a biomedical scientist can progress further in the field of cytology. 
PASSION FOR EXCELLENCE 
Working at the Royal Postgraduate Medical School was an instigator of this value 
at the beginning of my career in 1983. I became associated with esteemed 
pathologists who were internationally known as experts in their particular field in 
pathology. I was impressed by their refreshing approach to strive to achieve the 
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highest level in research and teaching. Their insatiable drive was not for 
monetary gain but to extend their knowledge for the benefit of the science.  This 
kindled the fire within me to follow their teaching and their principles in my 
discipline. For example at Ashford and St.Peter’s hospitals, I have continually 
worked with colleagues to ensure that we are at the forefront of the field often 
developing new techniques. Some of these recent initiatives were described in 
earlier public works 4, 5 and 6 
 
PUTTING PATIENTS FIRST 
Putting patients first must be a central objective to all people who work in the 
NHS. For laboratory disciplines, where direct contact with patients is limited and 
the focus of the work is with their samples, it is easy to forget this point.  I apply 
this value in my daily work, and emphasise its importance when I teach cytology 
to new trainees. My public works have  benefitted  patients directly  (public work 
no 3, 5, 6) or indirectly by either education (public works 2,7,8,13) and raising the 
standards (public works 1,2,4,9,10,11,12). 
 
COLLABORATIVE WORKING 
I learned from very early on that one can achieve considerably more if it is 
achieved through teamwork. This is evident by my public works as the majority 
are written in collaboration with colleagues. And in particular it is true of how I 
invited other authors to collaborate with me in writing the Cytopathology textbook 
(public work no 7).  Although I was given the opportunity to write the 
cytopathology book as a sole author, I decided that it would benefit the 
profession more effectively if it was delivered via collaborative working with other 
colleagues.  The success of the book has shown that this was the correct 
decision. 
 
 
COMMITMENT TO EDUCATION 
I believethat my personal involvement in the professional scene in the past 10 
years has contributed to increasing the knowledge and ensuring the continuing 
professionalization of biomedical scientists in cytology. As the chief examiner for 
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the past seven years I have had the responsibility of setting the examination 
papers for the higher scientific diploma (HSD). The HSD is set at postgraduate 
level to tests the candidates’ competence to practise professionally at the highest 
level.  I have ensured that each year the standards reflect the changing 
professional scene. As a member of the IBMS SAP for the past 15 years, I have 
been involved in organising the scientific content of seven IBMS congresses and 
also contributed by presenting papers in these conferences.  
 
My main public works have an education theme which I also believe have 
contributed to knowledge.  Public works 2 and 13 are training guides aimed at 
biomedical and clinical scientists respectively.  Public work number 8 is an 
educational self assessment aimed at raising the knowledge of pathologists and 
pathologists in training.Public work number 7 “Cytopathology” has the potential to 
increase the knowledge of non-medical cytologists in the UK.  
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CHAPTER 5  REFLECTIONS ON THE JOURNEY AND 
DIRECTIONS FOR CYTOLOGY IN FUTURE 
 
I had not fully appreciated the benefits of reflecting on past activities.  Reflection 
has unexpectedly produced new insights and knowledge.  Reflecting back, 
however, has proved to be a very difficult process.  Because of its nature it is 
highly personal, subjective and emotive. It requires various characteristics such 
as sensitivity, emotional intelligence and the ability to be self-critical and to 
provide a balanced analysis of events. I have tried hard to be honest and 
disclose events as they occurred and portray what I felt at the time.  Most of us 
feel uncomfortable disclosing our personal frailties. I am not dissimilar to most in 
this respect.  
 
My workplace, in the past 30 years, has been a medium for learning that I can 
confidently say would equate to anacademic research based qualification.  
Although my experience in pure academic research has been limited, many of 
the ‘real-life’ practical projects or public works that I have undertaken have 
directly influenced my own professional practice and those of others. And many 
of the works have improved service quality for the benefit of the patients.  
 
My public works have either a quality, educational, or service improvement 
theme. Although I have described each in detail before, below I have 
summarised how I believe they have made an overall contribution to my 
profession.  
 
The public works numbers 1 and 10 are quality documents produced by the 
NHSCSP. These documents have been influential nationally and all laboratories 
in England taking part in cervical screening refer to these publications. 
 
Public works numbers 2, 8 and 13 have a training and educational focus. Public 
works 2 and 13 are training guidelines that set the scope of expected practice 
from biomedical and clinical scientists respectively.  Public work number 8 is an 
educational self-assessment aimed at consultant pathologists and pathologists in 
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training. These works show that I have the ability to communicate clearly in 
writing by adjusting the content to reach different audiences to ensure different 
messages are understood. 
 
Public works numbers 3, 5 and 6 are in-house projects that have directly 
benefited the service and the patient. They are very similar in nature; exploring 
simple ideas in a novel way which show a measurable impact.  
 
Public works numbers 11 and 12 are clinical audits that show improvement in 
diagnosis, which has been clearly beneficial to patients.   
 
Public work number 9 is a formal report that I have to produce every year as part 
of my role as the regional external quality assurance scheme organiser. The 
process is quite mechanical in that I have to include participants’ performance 
figures. I tried, and feel that I have succeeded in adding educational elements to 
what would have been a very “dry” and formal report. 
 
Public work number 4 explores the concept of Lean to improve services, but also 
how Lean was used to improve team morale. 
 
Public work number 7 “Cytopathology” is a project which I am most proud of. It 
was my longest project. When I started the project, I really knew nothing about 
writing or editing. This was an incredible learning experience.  I am excited when 
I meet trainee biomedical scientists who have read the book and they tell me how 
it has contributed to their learning.  This book has the potential to influence the 
future of non-medical cytology education in the UK. 
  
From very early in my career Inoted a lot of incorrect assumptions about 
qualifications and competences that had not been challenged.  The assumption 
in cytology has been that a doctor is competent and a biomedical scientist can 
never become competent, no matter how much training the person has 
undertaken or experience they have gained.  I have shown through my own 
practice that this is an incorrect assumption and competence can be gained 
through professional practice. And indeed I now conclude that continuous 
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updating of knowledge is the main attribute of a profession. 
THE FUTURE FOR BIOMEDICAL SCIENTIST AND THE EMERGENCE OF 
NEW GROUPS OF SCIENTIFIC WORKERS 
The profession of biomedical science has continued to evolve in response to the 
changes in laboratory technology and the political and professional scene. In the 
early 1900s, with a limited repertoire of tests available in medicine, laboratory 
workers were employed with minimal qualifications to assist pathologists. By the 
1940s the range of laboratory tests expanded and the laboratory workers 
became technicians involved in carrying out these tests.  
 
By the 1970s, the role had become more scientific and the designation of 
laboratory technician was no longer appropriate; laboratory workers were now 
named scientific officers. Throughout the 1990s and 2000s, there were great 
strides in medical technology and most laboratory tests were carried out by 
automated analysers. This shifted laboratory medicine to become the clinical 
interpretation of test results.  
 
Cytology as a laboratory discipline has mostly survived the technological 
changes that have affected other pathology disciplines. Technology, however, 
promises to change the practice of cytology in the next five to six years (Public 
Health England, 2013) which will lead to a large scale reduction in the scientific 
workforce. 
 
In addition to the advances in technology, cytology has not escaped the effects of 
government policy on large scale centralisation (Department of Health 2005).  
Centralisation and changes in policy regarding scientific education (Department 
of Health 2010) has led to issues with recruitment in both the scientific and the 
medical sector, thus provoking the scientists and pathologists to engage in power 
plays in order to establish territory. 
 
The pathologists, who see the changing conditions undermining their original 
position, are employing tactics to retain and regain territory from biomedical 
scientists.  On the other hand, the biomedical scientists feel overwhelmed and 
threatened by changes in technology and are thrown into a defensive posture. 
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The prospect of machines taking over from the biomedical scientist has 
adversely affected recruitment in cytology.  In six to seven years time,it is 
possible that cytology will revert back to a sub-specialty of histology, employing a 
small number of scientists and pathologists. 
 
The biomedical scientist may need to evolve further to survive these changes. 
Indeed the promise of clinical scientists taking more responsibility in the 
interpretation of test results may need to be explored further.  
The AHCS (see appendix 4) is currently in the process of granting “equivalence” 
to existing biomedical scientists to become clinical scientists (AHCS 2013).  It is 
difficult to predict the impact of granting equivalence but it may rapidly increase 
the number of clinical scientists .The emerging clinical scientists could then be in 
a position to establish a new profession with extended roles in cytology. 
 
This will have a direct effect on the IBMS that until now has been a professional 
body for the biomedical scientists. The IBMS should extend its hand and openly 
invite clinical scientists to its membership or the clinical scientists will choose to 
form a new organisation and network and gain support from the Department of 
Health to self-regulate and in time form an all scientists profession delivering 
specialist cytology service.  I feel the former should be the route followed by the 
IBMS and the clinical scientists, and I believe that my contextual statement will 
contribute to this transformation. 
 
As I hope this context statement has shown challenging these existing 
assumptions has not been easy; it has been an uphill struggle with various 
professional bodies including my own professional body the IBMS who have 
failed to recognise that professions change over time.   
 
ACTION PLAN FOR THE FUTURE 
In the next 10-15 years I intend to help the biomedical science profession to 
evolve further. I will: 
 
• work with  the National School of Healthcare Science to ensure the cytology 
curricula of the scientific training programme (STP) meets the needs of the 
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service 
•  work with the Academy of Healthcare Science ( AHCS) to ensure biomedical 
can achieve clinical  scientist equivalence and gain registration with the 
HCPC 
 
• work with the IBMS council to ensure it develops into a stronger professional 
body  to represent and defend the needs of their members 
 
•  work with the RCPath cytopathology subcommittee members  to develop 
curricula for the Higher Scientific Training Programme (HSTP)  in the next five 
years to ensure clinical scientists can practice at consultant level 
 
• publish the second edition of the Cytopthology textbook to  reflect changes in 
cytopathology since the first edition 
 
• teach on the MSc and BSc courses to pass on knowledge and practical 
experience acquired over 30 years.  
 
 
I consider that the recognition of this work at doctorate level will also help to 
continue to champion further change in the profession. Although I am fully aware 
that changing the mind set of established medical professions will not be easy, I 
hope in the next ten years to see the role of clinical scientists in the UK to 
become the norm and gradually step-up to share diagnostic roles with medical 
doctors. This may be expedited as cytology is undergoing immense change 
technologically and this may dissuade newly qualified medical doctors from 
entering the discipline and leaving this void to be filled by clinical scientists.  
 
The main lesson I draw from the values I have been at pains to develop and 
apply over the years is that we are more likely to extend the boundaries of 
cytology by including pathologists in our future negotiations rather than by 
excluding them. In a way this is a contradiction of one of the characteristics often 
cited for a profession viz that profession protects its boundaries by exclusion. 
Nevertheless I will continue to do what I have always done which is to include all 
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colleagues, including pathologists; through collaboration we will all extend 
boundaries of “our profession”. 
 
I hope that by the time I end my career in cytology, my role as a Head of 
Department will not be an exception, but an accepted career path for senior 
clinical scientists.  
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Introduction 
The Royal College of  Pathologists,  through its Cytopathology  Sub-Committee, 
has  reviewed currentguidance regardingclinicalleadershipandresponsibility 
forcytopathology services1.In reviewingthisguidance,theknowledge and 
competencies required to make clinicaljudgmentsand delivereffective 
management have been considered. 
 
Cervicalcytology 
Itisnow 
tenyearssincethejointInstituteofBiomedicalScience/RoyalCollegeofPathologists 
AdvancedSpecialistDiplomainCervicalCytology 
wasintroduced.1Biomedicalscientistholders of this qualification,whoseexpertise 
iswell recognised and who arevaluedmembers of the cytology 
workforce,arereferred toas‘AdvancedPractitioners’.Insomecases,thoseholdingthis 
qualificationhavebeen 
appointedbylocalemployerstoconsultantbiomedicalscientistpostsin 
cervicalcytology.However,sincethereisnotastandardisedapproach 
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tosuchappointmentsas thereis 
forconsultantmedicalstaff,‘AdvancedPractitioner’isused forconsistencyinthis 
document. 
 
•
 TheCollegecontinuestosupportandendorsecurrentguidanceissuedjointlywitht
heNHS CancerScreeningProgrammes (NHSCSP)thatamedically 
qualifiedconsultantpathologist must 
takeresponsibilityfortheissueofallcervicalcytology 
results,eventhoughabnormal resultsmaybeissuedbyAdvancedPractitioners. 
 
•
 TheCollegecontinuestosupportandendorsecurrentguidanceissuedjointlywitht
he NHSCSPthatatleasttwomedically 
qualifiedconsultantpathologistswhoactively practise cervicalcytology 
areinvolvedintheserviceprovidedby anNHS Trust,a managed network 
coveringanumberofTrusts,oraprivatelaboratory,so thatone 
consultantpathologistis 
alwaysavailabletoprovidedirectiontostaff,includingconsultantbiomedicalscient
ists.2-4 
Furthermore, thatdirectioncanonly beeffectively providedifthe 
consultantpathologists practiseincervicalcytology atthelaboratory 
wherescreeningofcervicalcytology samplesis undertaken. 
 
 
 
Diagnosticcytology 
TheclinicalleadfordiagnosticcytologyservicesinaTrustorotherserviceprovidermustal
ways beamedically qualifiedconsultantpathologist, 
whomusttakeresponsibilityfortheissueofall diagnostic cytology  results, although 
reports on some specimen types may  be issued by biomedical scientists.5 
 
Justificationand reasoning 
Reasonsastowhy amedicallyqualifiedperson appointedat thelevelofconsultantis 
requiredto clinically lead acervical cytology laboratoryservice have been 
considered asfollows: 
 
 
1. Abroadknowledgeof clinicalpracticeandbasic  science  areregarded  as  
essentialto effectively  undertake  the direction and  individual case decision-
making in a  cervical screeninglaboratory. 
Thisbroadknowledgeisacquiredduringamedical trainingfollowedby 
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achievingFRCPath(orequivalent),leadingtoawardofaCCTin 
histopathology.The training 
andcertificationofAdvancedBiomedicalScientistPractitionersincervicalcytolog
y(APs) does not extendtothisbroadknowledge of clinical practiceand 
basicscience. 
 
2.    WhilstAPsareawareofcytology-
histologycorrelation,andcantherebycontributetoMDT 
discussions, they are not trained to interpret and report histology specimens 
that may 
emanatefromthecervicalscreeningprogramme,aswouldamedicalpractitionera
ppointed at thelevel ofaconsultantin histopathology. 
 
3.
 Thepersonleadingaservicewouldberequiredtomeetregularlywithmedicalcolle
aguesto review theircompetenciesandworkingpractices 
andseekimprovementintheirperformance if 
necessary.Theclinicalprofessionalperformance management 
ofmedicalconsultants should beperformedbyanother 
medicallyqualifiedpersonofequivalenttrainingandgrade. 
 
4. All medical consultants will be requiredto presentevidencein relation 
totheirclinical practice suitable for revalidation.APs arenotsubjectto 
revalidation,whichis believed to be an important qualitymeasureforstaff 
managingaservice. 
 
5.
 ThereisariskthatifAPsprovideclinicalleadershipofcervicalscreeninglaboratorie
s,it could 
resultinasignificantlossofexpertise,researchandinnovationthatmedical 
consultant pathologistsbringtothecervical screeningprogramme. 
 
6.
 ThereisariskthatifAPsprovideclinicalleadershipofcervicalscreeninglaboratorie
s,it wouldmakespecialisationincervical cytologyalessattractivecareeroption 
formedical 
traineesincellularpathology.Theabilitytorecruitmedicalstaffintothisareaofclinic
alwork isdeemedessentialat a timewhen thereisa move tofewerlarger 
cervical screening laboratoriesutilisingadjunctivemoleculartesting(HPV), 
requiringa cadreofhighly trained consultantcytopathologists. Thisis the 
rationale behindtheintroductionby theCollegeofthe Certificatein Higher 
Cervical CytopathologyTraining. 
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7. Use ofAPsto provideclinical leadership ofcervical screeninglaboratorieswould 
bea unique managerialmodel in histopathologyandcytology. 
 
8.
 Allthesepointsapplyalsotodiagnosticcytologylaboratories.Thesecond,thirdan
dfourth pointsabove areevenmorepertinentto diagnostic cytology; 
forexample,APshaveno trainingintheinterpretationofbiopsies other 
thancervical biopsies. 
 
9.
 Thespecificrequirementforconsultantstopractiseincervicalcytologyatthelabor
atory wherescreeningofcervical cytologysamplesisundertakenisinformedby 
the factthat problems  with  cervical  cytology   laboratory   management,   
governance  and  clinical performancearisewhereconsultantsarephysically 
separatedfromthelaboratory forwhich they 
areresponsible.Thiswasmostnotably 
highlightedintheSERHAreportintoeventsat Kent&Canterbury hospitalin 
thelate1980s/early1990s. 
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APPENDIX 3  PROPOSAL TO FORM AN ASSOCIATION 
OF ASSISTANTS IN PATHOLOGICAL AND 
BACTERIOLOGICAL LABORATORIES AND MUSEUMS 
(LETTER)
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APPENDIX 4 A SHORT HISTORY OF BIOMEDICAL 
SCIENCES 
 
I have referred extensively to Farr (1982) and Petts and Harding (2012) whilst 
preparing the text below.  
 
Biomedical scientists initially began as laboratory assistants employed to assist 
in histopathology and microbiology laboratories. They were often employed with 
minimal qualifications by hospitals and universities. Although highly valued by the 
pathologists, laboratory assistants were viewed as unskilled by the boards of 
hospitals and other controlling bodies, and as a result were often poorly paid 
when compared to other workers who enjoyed protection of trade unions (14).  At 
that time the relationship between the head of the laboratory and the assistants 
could be described as paternalistic; the assistant’s salary being supplemented 
directly by the pathologist.  
 
1912 to early 1960s 
The first formal organisation for non-medical staff was formed in 1912 by Albert 
Norman. The society was called the Pathological and Bacteriological Laboratory 
Assistants Association (PBLAA).  Albert Norman, the son of a Cambridge farming 
family, started work in a laboratory at the age of 14. He was aware of the low 
regard given to his occupation, with poor prospects and remuneration. This 
situation was his motivation and by the age the 29 he had recognised the need 
for a body that represented laboratory assistants. The paternalistic relationship 
between the pathologists and assistants is shown by the tone of the letter that 
was sent to the eminent pathologists at the Pathological Society asking for their 
permission to form the society (Appendix 3). The first president the new society 
was the pathologist, Professor James Lorraine. This trend of appointing medical 
doctors as presidents continued until 1975.   
 
By 1921 the PBLAA founder members had established an examination structure 
providing a qualification for laboratory assistants. Once again there were 
pathologists involved in the society as examiners.  For this exam there were two 
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pathologists and a member from the PBLAA who acted as an assessor.  By 1929 
an expanded syllabus was introduced to include the addition of pathological 
chemistry.  This represented the first acknowledgement by the PBLAA that the 
scope of medical laboratory science was expanding.  Six years later a two–stage 
qualification structure was introduced. A “Part I” based on elementary knowledge 
of routine duties.  After passing the Part 1 the candidate became “member” of the 
PBLAA. The members could take the “Part 2” examination after a further two 
years of in service training before they could be Fellows of the Association. 
Possession of the Part II certificate became a condition for employment to senior 
posts. Holders of the certificate found themselves in a better position, with 
improved status within the laboratory.  This was an important moment in the 
history of biomedical sciences when a manual trade was being elevated into an 
embryonic scientific profession. 
 
After the First World War and the expansion of healthcare provision during the 
1920s and 1930s, the membership grew. This period also saw the emergence of 
new disciplines of haematology and chemical pathology. By the late 1930s plans 
were already in hand to restructure the PBLAA into a “professional” institute 
which would more properly reflect the high level of technical skill that was 
required in medical laboratories.  
 
In 1942 the Institute of Medical Laboratory Technology (IMLT) was formed. The 
IMLT redesigned the membership grades, together with producing new 
qualifications. Examination boards were established to deliver the new 
examination. The names of the examination were also changed. The Part 1 was 
named Intermediate, with its own examining body consisting of Fellows of the 
Institute. Part 2 was named the Final examination with an examination board 
consisting of examiners (pathologists) and assessors (Fellows of the institute).   
 
Laboratory medicine was undergoing an expansive phase. New skills were 
required from laboratory workers, and the laboratory assistants became known 
as technicians. 
 
With expansion of the NHS, the government saw the need to regulate various 
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emerging professional groups. Various committees were established to enquire 
into the education, training and qualifications of various groups of staff. In 1960 
the bill to bring in state registration passed into law. This was called the 
Professions Supplementary to Medicine Act, 1960.  The act established a 
regulatory council called the Council for Professions Supplementary to Medicine 
(CPSM).  Its role was to supervise the activities of the boards established to 
represent the range of health professions that the CPSM regulated. The CPSM 
responsibility included providing registration of members, regulating their 
professional education and conduct and cancelling registration in cases of 
misconduct.  The Medical Laboratory Technicians Register began in 1963 and 
statutory registration became condition of employment from 1964. 
 
The 1960s 
During the 1960s the IMLT considered other qualifications for medical laboratory 
technicians including the National Certificate System. It was however reluctant to 
introduce this as there were concerns about loss of control over qualifying 
examinations. However it was agreed that changes in complexity of laboratory 
medicine that introduction of basic science was important. This and other 
changes in education in the NHS led the council to consider the introduction of a 
national certificate system. The Ordinary National Certificate was introduced by 
1966 and Higher National Certificate by 1968. The award of HNC lead to 
admittance to the class of Associate and holder could become state registered 
after three years employment in an approved laboratory.  In 1964, the IMLT 
council approved an advanced examination for Fellowship which was to be 
assessed at a higher level in the subject that the candidate had qualified in. This 
examination became known as the Special Examination for Fellowship and was 
introduced in 1966. The last intermediate exam was awarded in 1970 and the 
last Final examination in 1975. This is the time that the institute changed its 
function from a qualifying one to a professional body.  
 
The1970s 
Since the formation of PBLAA in 1912, the President had always been an 
eminent pathologist. In the 1962 WH Valentine, then the chairman challenged 
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this position. It took until 1974 for “the articles of association” to be amended to 
allow for any Fellow of the Institute to be appointed as the president. 
 
In 1976, Frank Baker became the first non-medical President of the IMLT.  He 
was passionate that the Institute should be in charge of its own direction and 
destiny without reliance on the medical profession.  
 
The Institute had also pursued a change of designation of qualified staff from 
technician since 1956.  In 1972 the Institute issued a policy statement entitled 
“Staffing in Medical Laboratories” where an increased scientific element in the 
laboratory was described. The paper compared the job roles to the Scientific Civil 
Service. In 1974 at a scientific conference held in Sheffield the president, 
Professor George Dick described the high level of qualification required of the 
profession, and argued that the term of technician was no longer appropriate for 
the members and they should be known as scientific officers. In 1975 the 
Institute changed its name to Institute of Medical Laboratory Sciences (IMLS).  
 
In 1976 the Institute was invited to give evidence to the Royal Commission on the 
NHS on the staffing of pathology laboratories. These resulted into two 
Department of Health and Social Security (DHSS) publications.  The Institute 
highlighted the outdated and unrealistic management structure. The comment 
attracted hostile comments from the pathologists as they felt threatened by the 
IBMS statement.  The institute soon published a statement titled “Pathologists 
and ourselves” to quell the animosity. The Institute had not challenged the clinical 
issues but there were disagreements regarding the laboratory management.  
 
The Institute tried to maintain a cordial relationship with the Royal College of 
Pathologists through holding regular meetings. But the relationship with the 
Association of Clinical Biochemists (ACB) and Association of Clinical 
Pathologists (ACP) were not harmonious during this time as these organisations 
openly stated that only senior scientists or pathologists should undertake 
laboratory management. In 1978 an acrimonious dispute developed in Scotland 
regarding the management arrangements in the Fife Health board. This resulted 
in a bitter dispute between the two unions: the Association of Scientific, Technical 
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and Managerial staff (ASTMS) and the British Medical Association (BMA). 
 
The 1980s 
The Institute council had been debating changing the membership structure for 
years. The previous structure consisted of two classes; the class of Associate 
and the class of Fellowship. It was not unusual for many of the members to 
obtain the Fellowship by examination early in their careers. This made the 
Institute different from other societies in that it had too many Fellows and this 
devalued the status of the Fellowship. The suggested changes would allow the 
existing Associates and Fellows to retain their class of membership and continue 
to use the post-nominal letters of AIMLS and FIMLS after their names. The new 
structure was suggested in 1983. It proposed four classes of “non-corporate” 
class of membership; Affiliate, Student, Associate and Licentiate, with two 
classes of “corporate membership”, Member and Fellow.  However it was not 
until 2008 that this membership structure was implemented. 
 
There were moments in the history of the Institute that a biomedical scientist 
raised issues about the professional relationship between biomedical scientists 
and the medical profession.  Once such person was Jim Cloke who was 
appointed to the council in 1985. He noted that the need for a hospital pathologist 
to interpret data was rapidly declining and so was their consultative role. He said 
that this evolutionary process was becoming a handicap to the scientific 
profession as pathologists were in many cases trying to take on the managerial 
and administrative responsibilities to supplement their diminishing role.  
Another scientist was R l Ward, who in an article in September 1985 published in 
The Gazette entitled “As others see us”, summarised the issues confronting the 
profession. He noted that the government viewed the medical laboratory  
scientists  as “back water” professional as they “did not deal with patients”. He 
felt that this was a handicap as it did not give the Institute enough negotiating 
powers. He believed that the Institute should raise its profile and engage in public 
relation activities. This opinion was however at odds with the council on two 
fronts; first, adopting a confrontational stance was alien to the Institute policy and 
secondly, it had no experience in public relations. In 1986 the Institute decided to 
engage a professional public relation company research this issue.  
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The organisation and its members were experiencing increasing levels of attack 
on their professional position. This was mainly from the government who failed to 
see the vital role the biomedical scientists played in diagnosis. The government 
also did not acknowledge that senior members of profession were performing 
effectively in their managerial position. The Institute attempted to address this by 
continued communication with the Secretary of State for Social Security and also 
by establishing management courses. 
 
During 1987 there were several issues that drew adverse publicity.  A disclosure 
about misreporting of cervical smears in Liverpool; and an article published in 
The Daily Telegraph on 14 July 1987 reported that British Society for Clinical 
Cytology (BSCC), a medical society, stated that “poor or non-existent training of 
laboratory technicians contributed to 2000 deaths a year”. This article was 
factually incorrect and a direct attack to Institute members. The true extent of 
errors surfaced when a report published by Liverpool Health Authority entitled 
“Internal Review into Laboratories at the Woman’s hospital, Liverpool”. The report 
stated that there were 911 false negative errors and these misdiagnoses were 
attributed to two pathologists Dr Kathleen Lodge and Dr Percy Jones. The report 
praised the action of medical laboratory scientific officers and said “in the 
absence of their initiative  this problem would have remained undisclosed”. The 
Institute undertook an intensive press relations campaign to explain the role of 
medical laboratory scientist. 
 
During the 1980s there was increasing political and public mistrust of self 
regulation amongst professional bodies.  Although biomedical scientists were 
registered, there was no formal system of ensuring that they kept their 
knowledge up do date. In 1989 the Institute set out objectives for a Continuing 
Professional Development (CPD) scheme. This scheme was officially launched in 
March 1990, and revised in 1992 and again in 2002 when a new credit system 
was introduced that included reflective learning.  The CPD scheme became 
mandatory in 2006 for members continuing registration with Health Profession 
Council (HPC-replaced CPSM in 2001).  
The Department of Health introduced a new grading structure for the NHS 
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pathology staff at the end of 1988. This reduced the number of grades from 
seven to five. It also introduced the new grade of Medical Laboratory Assistant 
(MLA); a non-career grade for support staff.  There was concern that this new 
post could undermine the status of the role of qualified staff.  The new structure 
potentially had severe implications for the Institute as senior grades were no 
longer required to hold the Fellowship of the Institute.  In reality most employers 
continued to require these qualifications for senior grades. New entrants however 
did not see the need to join the Institute and as result between 1988 and 1990 
total membership fell by nearly 20%.   
 
The late 1980s and early 1990s were an era of great change and upheaval for 
both the Institute and the profession.  The change in staffing structure, and the 
introduction of the internal market in the NHS caused further insecurity. Many 
members felt that the Institute was impotent and unable to influence events. 
 
The 1990s 
The first graduates became members in 1936. From then on a steady trickle 
joined the institute. By 1949 the number of graduates entering the profession had 
risen. It was agreed to allow exemption from the Final examination to the science 
graduates who had one year’s experience in an approved laboratory. There was 
initially some opposition to graduates, mostly by senior members of the 
profession who felt the graduates did not have the equivalent practical abilities to 
the traditional laboratory scientist. This attitude however changed in time. By 
1974 about 10% of those joining the Institute and 20% recruited as medical 
laboratory technicians were graduates.   
 
The universities began to explore the possibility of offering degrees with 
curriculum broadly equivalent as an honours degree in biomedical science.  The 
two pathways of HNC and degree continued until the early 1990s. The Institute 
took the view that they should move to an all graduate entry. The CPSM also 
took a similar view and from September 1993 required all new registrants to have 
an appropriate science degree. The role of the Institute in formal education 
changed again and its involvement in formal education became approving BSc 
and MSc courses. 
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In 1993 at the Annual General Meeting the president, David Browning, proposed 
a special resolution to change the name of the Institute from IMLS to the Institute 
of Biomedical Sciences (IBMS). The president said that the new name would 
reflect more accurately the Institutes broad membership base and widen its 
influence. 
 
In the early 1990s there were a series of high profile legal cases in cervical 
screening that highlighted problems with laboratory quality and service. This was 
partly due to a shortage of pathologists who were not willing to participate in the 
cervical screening programme. This shortage was partially fulfilled by ad-hoc 
appointment of clinical scientist; but at that time there was no statutory regulation 
of clinical scientists; but and this was not a satisfactory long term solution. In 
2000, the NHSCSP asked RCPath and the Institute to setup a training 
programme and qualification structure for biomedical scientists involved in 
reporting of cervical smears.  The new qualification named the Advanced 
Specialist Diploma in Cervical Cytology became mandatory for appointment as 
an Advanced Biomedical Scientist Practitioner in Cytology.  
 
 
In 1996 the Department of Health proposed changes to the PSM act.  The draft 
bill was completed by 1997. One of the requirements of the new acts would 
require registrants to keep up-to-date with their profession by maintaining 
evidence of Continuing Professional Development (CPD). Although the bill was 
ready by 1997, it was not until 2002 that the Health Profession Bill became Act of 
Parliament.  
 
The 2000s 
In 2002 the Health Professions Council (HPC) became the registration authority. 
The IBMS took over the responsibility of issuing a certificate of competence to 
new registrants. This new activity and the mandatory participation in CPD led to 
an increase in number of members.  
 
One aspect of the consultation with the HPC was “protected titles”.  As the name 
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suggests, a protected title is protected by law, and anyone using these titles must 
be registered with the HPC. In September 2004  title of Biomedical Scientist was 
accepted and became a protected title. 
In 2004 the Science Council awarded the IBMS Licensed Member body status. 
This allowed the IBMS to award Chartered Scientist (CSci) designation to 
appropriately qualified and experienced members.  
 
In 2005 an Independent Review of Pathology Services was established. The 
review was chaired by Lord Carter of Coles.  The first report published in 2006 
examined issues relating to quality, timeliness, reliability, capacity, and efficiency 
of current pathology services in England. It also investigated the feasibility and 
benefits of arising from wide-scale service reconfiguration, innovation and 
modernisation, and involvement of the independent sector.  
 
The IBMS response to this report was varied. Although it welcomed the focus on 
quality, it could see that large service reconfiguration would reduce staffing 
numbers and ultimately its membership. In its formal response published on the 
IBMS website acknowledged that potential savings could be realised by mergers 
between pathology laboratories, but expressed its concern about the potential 
loss of quality, or loss of existing skilled staff.  In practice, mergers have led to 
loss of expertise as many members have left the profession or taken early 
retirement when faced with prospect of change.  
 
In 2008 the Department of Health announced a new staffing structure under the 
direction of Chief Scientific Officer, Professor Sue Hill. The scheme called 
‘Modernising Scientific Careers’ (MSC) originated from a report called ‘A high 
quality workforce’ published by Lord Darzi’s Review of the NHS. The scheme 
provided a single framework for all the healthcare science. This led policy 
consultation document which outlined a revised training structure for the 50,000 
plus healthcare scientists in the disciplines. The final policy proposals were 
published in February 2010 in the document 'Modernising Scientific Careers: The 
UK way forward'.  
 
The MSC initiative promised the introduction of a new simplified four stage career 
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pathway, new education and training programme, identification of regulatory 
implication and support for delivery of the proposed changes. The four new MSC 
career pathways consisted of : 
• Assistants and Associates 
• Practitioner Training Programme (PTP) - Bachelor-level education 
• Scientist Training Programme (STP) - Masters-level education 
• Higher Specialist Scientific Training (HSST) - Doctorate level 
•  
The IBMS response to the initial 2008 paper was rather muted as the initial DoH 
paper did not give sufficient details on the proposals. In 2009 the MSC team 
produced the next consultation paper titled ‘Modernising Scientific Careers: The 
Next Steps’. The IBMS response to this paper was stronger in tone. IBMS saw 
the MSC as challenge to its established proven education and qualification 
systems. This was not without reason as the MSC proposals did not give 
sufficient detail.  The IBMS argued that the current education and training system 
for biomedical scientists had delivered a safe, well regulated, fit for purpose 
profession that met the needs of the service.  The final policy document was 
published in February 2010 in the document 'Modernising Scientific Careers: The 
UK Way Forward'. The IBMS felt frustrated that the MSC had not considered any 
of its proposals and was about to dismantle a mature profession with an 
established career structure. The IBMS council was so concerned about MSC in 
relation to biomedical scientists, their HCPC registration, and protected title that it 
felt compelled to write directly to ministers to highlight the potential 
consequences to service delivery and patient safety. In 2011 the IBMS 
recognised that it would still need to continue with its previous education 
programme for the foreseeable future. It continued to assess biomedical science 
degrees that would lead to HPC registration as a biomedical scientist. 
 
It is now five years since the initial paper on the MSC was published. It has 
become clear that not all career levels promised have been fulfilled.  
The uptake for the PTP has been low. The STP has had marginally better 
interest. This is partly due to central funding as trainees receive a salary and 
funding to attend university leading to masters qualification. 
 
The fourth career pathway the HSST which would lead to a doctorate has hit the 
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buffers. The development of this programme depended on the cooperation of 
medical societies and yet again the medical profession protectionism has 
prevailed, and in cytology and histology this route has been blocked by the Royal 
College of Pathologists.  This will have a major impact on recruitment of 
cytologists into the MSC programme, as candidates are quite likely to choose 
one of the other pathology disciplines that will allow career progression. 
 
The ramifications of the MSC programme will not be known for sometime, and 
sadly there is always a gap between theory and practice when policies are made 
in the NHS. Models are unrealistic and there is poor support to turn desired 
practices into reality. 
 
In 2012 the Academy for Healthcare Science (AHCS) was established as a joint 
initiative between the UK health departments and the professional bodies.  
 
The academy’s role includes developing regulation for voluntary registration in 
healthcare science  disciplines where none existed. The AHCS is also developing 
a system for assessing equivalence that may be beneficial to the biomedical 
scientists. Equivalence in this scenario refers to the education, training, 
qualifications, and experience that a scientist may already have which is 
comparable to the new MSC qualifications.  The process of assessing 
equivalence will allow biomedical scientists who have qualifications or 
considerable experience relevant to the MSC programme have their experience 
and qualifications assessed and be granted a Certificate of Equivalence,which 
could allow them to register as a Clinical Scientist with HCPC.  
 
It is too early to predict the impact of AHCS awarding Clinical Scientist 
equivalence on membership of the IBMS. The membership of IBMS has up to 
now consisted mostly of biomedical scientists. It is not certain that once 
biomedical scientists can gain registration as Clinical Scientist, they would wish 
to continue their IBMS membership. 
 
The IBMS started life as an association for laboratory workers 100 years ago. Its 
stated aim in 1912 was to improve communication amongst its members. The 
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development in medical technology over the last 50 years has had a profound 
effect on the laboratory medicine. Analytical procedures and equipment have 
increased in complexity and the IBMS has reacted through involvement in 
education and setting professional standards. However in the past 10 years all 
medical professions have been under increasing pressure from various 
government initiatives. In my opinion the IBMS has not been proactive in its 
actions in positioning itself in the changing world of pathology, and unless 
changes are made its future remain uncertain.  
 
With its aging membership demographic, the next ten years will see a reduction 
in its membership, unless new members can be recruited its activities in its 
current form will not be sustainable.   
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APPENDIX 5  LIST OF PUBLISHED PUBLIC WORKS 
1External Quality Assessment scheme for the evaluation of 
Papanicolaou staining in cervical cytology, protocol and standard 
operating procedures.National Health Service Cervical Screening 
Programme (NHSCSP) Publication No. 19 2004 
Available from:  
http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp19.htm 
 
2 Institute of Biomedical Science (IBMS) record of laboratory training 
for the Specialist Diploma in Cytopathology. 2005 
 
Available from: 
http://www.ibms.org/go/qualifications/specialist-diplomas/application-
reference 
 
 
3 Collection fluid helps preservation in voided urine cytology. 
Cytopathology Raistrick J, Shambayati B, Dunsmuir 
2008 Apr,19 (2) 111-7 
 
Avaialble from : 
http://www.ncbi.nlm.nih.gov/pubmed/18352862 
 
 
4 Using Lean to lead change.Poster presentation carried out as part of 
NHS leadership programme “Influencing the future”-B.Shambayati 2010 
 
Available from: 
http://www.phoenixconsultancy.org/uploads/files/Using_LEAN_to_Lead_Change..
.-B_Shambayati_(pdf).pdf 
 
 
5 Effectiveness of endobronchial ultrasound (EBUS) in obtaining 
mediastinal lymph node samples for immunohistochemistry at a new 
district general hospital (DGH) service. Gulammehdi H, Shambyati 
B,Wood MPoster presentation.European Respiratory Society annual 
congress, Barcelona 2010 
 
6 Does immediate cytological analysis at bronchoscopy lead to 
reduced number of biopsies?  C. Eruchie, M. Manalo, B. Shambayati, P. 
Murray 
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Poster presentation.European Respiratory Society annual congress, 
Amsterdam 2011 
 
7-Cytopathology, Shambayati BEd, Oxford University Press, Oxford. 2011 
 
8Self assessments in Lower respiratory tract cytology, Shambayati B 
Diagnostic Histopathology Volume 17:2 February 2011 
 
Available from : 
http://www.sciencedirect.com/science/article/pii/S1756231710001891 
 
 
9 South East Coast Region, NHS Cervical Screening, National 
Gynaecological Cytopathology External Quality Assessment (EQA) 
Scheme Annual Report.  May 2012 
 
 
10 Achievable standards, Benchmarks for reporting and criteria for 
evaluating cervical cytopathology.(2013) 
 
Available from: 
http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp01.html 
 
 
11- Mesothelioma diagnosis in a district general hospital. 
Poster presentation-European Respiratory society annual congress , Vienna 
S. Sharma, K. Wimble, B. Shambayati, M. Wood (Chertsey, United Kingdom) 
2012 
 
 
12-Retrospective audit of malignant mesothelioma diagnosis in a 
District General hospital. Poster presentation at the British Association for 
Cytology annual scientific meeting Keele S. Sharma, K. Wimble, B. 
Shambayati, M. Wood 2012 
 
Available from: 
http://www.ers-education.org/ersMade/abstract_print_12/main_frameset.htm 
 
 
 
13 -Scientific Training Programme learning guide in Cytopathology 
Department of Health Modernising Scientific Careers (MSC), 2012 
 
Available from: 
http://www.nshcs.org.uk/assessment/learning-guides-2/ 
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APPENDIX 6  PUBLIC PRESENTATIONS 
 
Public presentation #1 Computers in cytology 
Southern Cytology Society, Worthing Hospital. November 
1991 
 
This short talk was given to 70 cytologists on setting a 
computer system in cytology. Until early 1990s all 
pathology laboratories worked on a purely manual “day 
book” and card file system. The daybook system worked 
well, but it was very difficult to gather data for 
management purposes. In the early 1990s computing was a 
relatively new concept in pathology and there were very 
few “off the shelf” systems. Most databases had to be 
built by the user with very little help from an IT 
company.  St.Peter’s hospital worked with the regional 
computer IT team to develop a pathology IT system. The 
IT team, after consultation with the users, set out to 
develop five pathology modules; histology and cytology, 
chemistry, haematology and microbiology.  The cytology 
system was well written well and was user friendly. 
However this project proved to be another NHS IT white 
elephant as its funding was removed before the 
microbiology module could be completed. The system could 
not be sold as a complete pathology system and we also 
had to abandon our module after five years and purchase 
a new system. This talk was well received and gave me 
the confidence to get more involved professionally. 
 
Public Presentation #2 Fine needle aspiration of head 
and neck 
Cellular pathology update. Guys Hospital, April 1994 
 
The cytology of the head and neck is a broad subject and 
it would have been difficult to cover this complex topic 
in one hour. Instead I decided to briefly discuss the 
cytology but concentrate on running of our FNA clinic. 
This proved to be a wise decision as I had many requests 
for protocols and procedures from the delegates. I was 
rather surprised by the responses I received even weeks 
after the talk, as although many worked in London 
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teaching hospitals, the practice of running an FNA 
clinic by a biomedical scientist was foreign to them.  
In most hospitals it was the pathologist who provided 
support for the FNA clinic.  This gave me an indication 
that maybe, by presenting good practice, I could 
influence and facilitate change. 
 
 
Public Presentation #3 Wise before the event 
Thames Valley Cytology Society, Ealing Hospital. 
November 1994 
 
This presentation told the story of the St.Peter’s 
Hospital screening incident from the time it was 
discovered until its conclusion. It detailed the actions 
that were taken from the time of discovery of errors to 
it’s conclusion when affected women were treated.  
 
It was not an enjoyable lecture to give. I suspect the 
audience also did not like what they heard, as it was 
too close to home for many. What happened at St.Peter’s 
hospital and many other hospitals throughout the late 
80s and 90s was the result of increasing workload, staff 
shortages, and lack of adequate quality assurance 
measures. 
 
 
Public Presentation #4 Too many qualifications for 
cytologistsIBMS Congress, International Conference 
Centre, Birmingham. September 1994 
 
This was a debate with a biomedical scientist colleague. 
I firmly argued the case that it was through education 
and proof of competence (qualifications) that biomedical 
scientists could progress in their careers and take on 
additional responsibilities. I quoted from Nelson 
Mandela’s autobiography, Long Walk to Freedom: 
“Education is the great engine of personal development. 
It is through education that the daughter of a peasant 
can become a doctor, that the son of the mine worker can 
become head of the mine, that a child of the farm worker 
can become the president of a great nation. It is what 
we make out of what we have, not what we are given that 
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separates one person from another”. 
 
My colleague argued the opposite; that we have made a 
rod for our own backs by creating too many 
qualifications. She said that these hurdles had put off 
many biomedical scientists from entering the profession. 
Other biomedical science disciplines, such biochemistry 
or haematology did not have as many post registration 
examinations. 
 
My colleague’s arguments were valid; in the 1990s 
cytology laboratories were grossly understaffed and 
departments had backlog of work of up to 12 weeks. New 
graduates chose other biomedical science disciplines in 
preference to cytology.  
 
The situation in 2013 is similar to the 1990s; the 
laboratories are short staffed and very few new trainee 
cytologists are entering the profession. This time 
though, the main reasons are changes in automation and 
technology that has  questioned the need for cervical 
screening using light microscopy, and employing staff to 
read them manually. 
 
The debate was well received as it made the delegates 
think about the future.  
 
Professionally for me this was the first time that I 
debated on a politically charged issue. It felt 
different to the usual scientific lecture that expressed 
facts.   
 
 
 
 
Public Presentation #5 Advance Practitioner in cytology 
personal views.  
IBMS congress,International Conference Centre, 
Birmingham. September 2001 
I described my exciting new role as an advanced 
practitioner reporting abnormal cervical cytology in a 
District General hospital. The profession was encouraged 
to respond to this development but at the end of the 
talk I alluded to the RCPath statement that was 
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deliberately written to limit the career opportunities 
for this new grade of staff.To to my surprise I did not 
get the responses that I had expected. I felt that the 
audience were politically naïve, and not looking to the 
future. It appears that most AP’s accept being 
supervised by medical colleagues and are unwilling to 
argue that their professionalism and qualifications are 
more than adequate to the task.  
 
 
 
Public Presentation #6 Cytology: A dinosaur facing 
extinction Southern Cytology Society, Kingston hospital. 
October 2004. Thames Valley Cytology Society, St.Mary’s 
Hospital. December 2004 “” 
 
Diagnostic cytology as discipline has been in slow 
decline since the 1960s. In my talk I referred to the 
1960s as the “golden age” of cytology. In 1960s the 
clinicians were “experimenting” with cytological 
sampling and Fine Needle Aspiration (FNA) was used 
extensively to sample different tissue sites. The 
laboratories were inundated with varied cytology samples 
that made the job interesting and challenging. This 
however changed over time as different treatment regimes 
for cancer demanded a more specific diagnosis that 
cytology could not offer. Clinicians slowly replaced the 
cytological samples with tissue biopsies. This change in 
practice had a major impact on the workforce as in the 
1980s the cervical cytology workload increased 
exponentially due to introducing cervical screening 
programme.  
 
Cervical screening in 2004 was also undergoing 
transformation.  
All medical advances begin with technological change; 
indeed it was the invention of the microscope, shifted 
that diagnosis from the patient to tissue level. 
 
The technological changes facing cytology in 2004 were 
based around the introduction of digital imaging, which 
promised to replace the workforce, and the introduction 
of prophylactic vaccines, which would stop cervical 
cancer from developing and should theoretically remove 
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the need for cervical screening. 
 
Dinosaurs were slowly undergoing background extinction 
as they were too slow to react to changes in the 
environment. But it was a catastrophic event (Alvarez 
meteoroid impact theory) that caused mass extinction. 
Are cytologists the pathology dinosaurs? 
 
I concluded that cytologists can avoid extinction if 
they adapt to change and gain new skills.   
 
 
 
Public Presentation #7 Career planning for cytologists 
IBMS Congress, International Conference Centre, 
Birmingham. September 2005. 
Repeated for Southern Cytology Society, Guys hospital 
London. October 2006 
 
This joint presentation with the Chief Examiner at the 
IBMS Congress was given to help raise the awareness of 
biomedical scientists, so they could plan for changes 
that were facing the profession in 2005.  
 
I introduced the talk by with a historical look at 
cytology as a discipline and changes that have occurred 
in the past 20 years. Then I looked at the immediate 
future such as introduction of new liquid based 
technology and changes in recall period of patients that 
would lead to decrease in cervical smears. Lastly I 
examined the major impact of introducing molecular 
testing for Human Papilloma virus (HPV) DNA. This has 
resulted in a huge improvement in cervical cancer 
screening, but would lead to a reduction the number of 
people required to read the smears. 
 
My colleague looked at the NHS Plan (Department of 
Health 2000) which promised to modernise the workforce 
and the pay through linking pay to the skills and 
competence. The NHS Agenda for Change also promised to 
remove professional boundaries (in 2013, this has not 
occurred). She then discussed the IBMS’ qualification 
strategy that was being developed to evidence knowledge, 
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skills and competencies. 
 
The conclusion looked at a future that would offer new 
opportunities but would require acquisition of new 
skills and developing new networks and alliances.    
 
 
Public presentation # 8 BMS role in non-Gynaecological 
cytology  
Scottish Association for Clinical Cytology, Perth May 
2006 
 
I was invited to give a talk on the role of biomedical 
scientists in non-gynaecological cytology at the 
Scottish Association for Clinical Cytology. The talk 
described my role at Ashford and St.Peter’s hospitals 
and offered various possibilities for biomedical 
scientists to get involved in diagnostic cytology.  
 
To my surprise I discovered that not a single biomedical 
scientist in Scotland was involved in any aspects of 
non-gynaecological cytology. Pathologists in general 
undertook the majority of the work at the expense of the 
biomedical scientist. Unlike England there was no 
shortage of pathologists in Scotland. Was this 
difference in practice purely due to a different 
economical model?  
 
My scope of practice in non-gynaecological was unusual 
(with the exception of a colleague in Kent). But it did 
not happen by chance; I nurtured and developed it over 
many years. Talking to colleagues who also had a limited 
role in reporting non-gynaecological, it came to light 
that they had also developed it.  
 
I concluded that my Scottish colleagues had not yet 
considered the technological changes that were to come 
which would affect the screening programme 
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Public presentation # 9 Biomedical Scientist 
Practitioners in non-gynaecological cytology: 
professional qualification, structure, training and 
examination format  
BSCC Northern Spring Tutorial, Manchester Royal 
Infirmary, March 2007. 
 
This was not the first time that I was urging the 
biomedical scientists to diversify. Although the 
prospects of molecular testing for cervical cytology was 
still some years off, I was still concerned that many 
biomedical scientists were still only focusing on 
cervical cytology. I was alarmed when during the break I 
talked to newly appointed graduates who told me that 
non-gynaecological cytology in their departments was 
solely practiced by pathologists. I hoped that my 
presentation would inspire some reflection on current 
practice. 
 
Public presentation # 10 Extending the roles in non-
gynae-A UK perspective  
17th International Congress of Cytology Edinburgh, 
Scotland, May 2010. 
 
This talk given to an international audience celebrated 
the UK’s achievement in involving biomedical scientists 
in non-gynae cytology. In many European countries and in 
the US, the role of biomedical scientist is still 
limited to the screening of cervical smears, as 
pathologists have managed to totally exclude biomedical 
scientists.  During the break I spoke to many European 
colleagues who felt frustrated by a lack of progress in 
their counties, and felt threatened by changes that 
technology was about to bring. 
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APPENDIX 7 CYTOPATHOLOGY REVIEWS 
Amazon.co.uk reviews 
 
Excellent modern text book written in a conversational 
style. Very different to other text books, lots of 
references and a great resource. Self assessment 
questions as you go along and further reading questions 
at the end of each chapter to help you understand each 
topic. Suitable for anyone interested in cytology, lots 
of pictures will make an excellent reference atlas. 
 
A well written and structured text on cytopathology. It 
takes you on a journey in cytology, bringing the subject 
to life with numerous colour photographs and drawings. 
It covers the basic topics, and the last 7 chapters 
cover the more complex subjects including molecular 
pathology. The layout is good and easy to read; it does 
not cloud you with heavy jargon and explains every new 
termed introduced to ensure the subject is understood, 
quite different to other books in cytology. 
 
This book is a must have for anyone who practices 
cytology whether it be in the UK or from overseas. The 
book is very well presented with easy to read text with 
key points, summary features, self assessments, case 
studies and definitions of terminology and procedures 
throughout. The book is full of high quality diagrams 
and photographs to support the text and aid the learning 
process. This book is suitable for 
cytoscreeners/cytotechnologists, biomedical scientists, 
trainee pathologists and consultants. It is an excellent 
reference book for anyone studying City and Guilds 
Diploma in Cervical Cytology, Advanced Specialist 
Diploma in Cervical Cytology, Diploma in Expert Practice 
and FRCPath. This book is excellent value for money and 
certainly fills the gap in the market. 
 
I read this book when I was working on my placement in a 
cytology lab. It's really easy to read, and to 
understand for anyone, who like me, knows only very 
basic cytology from what they've done on their degree. 
The many pictures make it very easy to understand what 
the text is describing. It's really bright, which for a 
science-based book is really impressive, as so many 
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books on similar subjects look so boring. It gave me 
enough information to have a good understanding of the 
subject, and to make the most of my placement. I would 
definitely recommend it!! 
 
This book hits the spot! Many text books are far too 
daunting for the average trainee cytoscreener or trainee 
biomedical scientist. This, however, covers the basics 
of gynaecological and non gynaecological in just enough 
detail to enable trainees to gain the knowledge needed. 
The diagrams and images are clear and contribute to the 
quality of the text. The self check questions and 
discussion questions serve to ensure understanding and 
promote further study. The content of the gynaecological 
section will be invaluable to those studying for the 
City & Guilds Diploma and the non-gynaecological section 
is equally as useful to biomedical scientists wishing to 
complete their Specialist portfolios or Diploma in Non-
gynaecological cytology. I would recommend this book to 
every lab as a useful addition to their library. 
 
A really great new cytology book that is definitely the 
best on the market. Loads of excellent photographs to 
bring the subjects to life and the text is presented in 
a clear and logical manner. It even covers semen 
analysis very comprehensively, while chapter 13 entitled 
"Advances in cytopathology" ensures the material is bang 
up to date. Every lab must have a copy of this book on 
the shelf! 
 
As the title suggests, this book covers all aspects 
relevant to the subject of cytopathology and makes for 
easy and interesting reading. The layout is excellent 
with clear and good quality photographs. The keyword 
boxes in the margins give concise definitions and are a 
great help. This book is an excellent aid for students 
and practicing cytologists and I would definitely 
recommend it. Great value! 
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APPENDIX 8  CURRICULUM VITAE 
 
C U R R I C U L U M  V I T A E  
 
B E H D A D  S H A M B A Y A T I  
M S c  C S c i  F I B M S  
 
E m a i l :  
B e h d a d . S h a m b a y a t i @ a s p h . n h s . u k  
 
. 
Present Post: Specialty Lead /Hospital Based Programme 
Coordinator/Person Responsible for HFEA 
Employer: Ashford and St. Peter’s Hospitals NHS 
Foundation Trust 
 
EDUCATION AND QUALIFICATIONS 
RCPath/IBMS Advanced Specialist Diploma in Cervical Cytology 2001 
IBMS Examination in Interpretive and Diagnostic Cytology  1998 
MSc in Clinical Cytotechnology, (Distinction)    1996 
Imperial College Diploma in Cytology      1995 
Diploma in Management Studies (DMS)(Merit)    1992 
IAC Registry Examination (Recertified)     1991 
BSCC Certificate of Competence      1989 
FIBMS by examination       1988 
HNC in Medical Lab Sciences      1986 
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AFFILIATIONS 
Health Profession Council (HPC) Clinical Scientist registration CS09983 
Chartered Scientist 109/000087 
Fellow of Institute of Biomedical Science (00123536) 
Member of British Society for Clinical Cytology (88003583) 
CPD 
I take part in both the Royal College of Pathologists and the Institute of 
Biomedical Sciences CPD schemes. 
 
AWARDS 
Cytology Team; winner of Ashford and St.Peter’s Hospitals Staff awards 
“Pride in Our Team” award - March 2011  
Personal Nominee for Ashford and St.Peter’s Pride in Our Team Award. 
March 2010 
Best Presentation – DOH “Influencing the Future Leadership Progarmme”- 
June 2010 
NHS Improvement Certificate of Excellence “for outstanding performance 
and exceptional commitment to team work” - 2009 
 
EMPLOYMENT HISTORY 
September 2011-present 
Surrey Pathology Service, Ashford and St. Peter’s Hopsital NHS Trust 
 
Job title Specilaty Lead-…Consultant Clinical Cytologist 
 
Responsibilities Service provisions across three hospitals; Ashford 
and St.Peters Hospitals Foundation Trust., 
Frimley Park hospital Foundation Trust  and 
Royal Surrey County Hospital  
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Achievements  Integration of cytology services. 
    Implementation of HPV testing in Surrey 
 
 
September 2006- September 2011   
Cytology Department, Ashford and St.Peter’s Hospitals NHS 
Foundation Trust                            
Job title Consultant Clinical Cytologist /Hospital Based 
Programme Co-coordinator 
Responsibilities Successfully combine a managerial/clinical role 
within the department. Nominated scientific lead 
and Hospital Based Programme Coordinator 
across the cytology and colposcopy services. 
Report abnormal cervical smears and non-gynae 
samples including Fine Needle Aspirate and 
EBUS samples  
Achievements In collaboration with NHS Improvement agency 
redesigned cervical cytology service using Lean 
methodology 
 Setup onsite microscopical assessment of 
sampling adequacy for all FNA, Bronchoscopy 
and EBUS procedures  
 
 
April 2001-Sept 2006 
Cytology Department, Ashford and St.Peter’s Hospitals NHS Trust 
Job Title: Clinical Cytologist  
Responsibilities: In technical charge of the Department to include 
clinical reporting of abnormal cervical smears and 
selected non-gynaecological cytology samples 
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Achievements Lead a seamless merger of Ashford and 
St.Peter’s laboratories to a single site.   
 Successfully tendered for cervical screening 
backlogs and provided services for 28 
laboratories in the UK, providing significant 
income for the Pathology department. 
 
Nov 1997- April 2001             
Cytology Department, Ashford and St.Peter’s Hospitals NHS Trust 
Job Title: Clinical Scientist Grade B 
Responsibilities: In technical charge of the two cytology 
departments with some clinical duties 
Achievements Unification of the two laboratories’ procedures 
prior to single site working 
 Setting up a fine needle aspiration service at 
Ashford Hospital 
 Setting up a rapid same day breast cytology fine 
needle aspiration service at Ashford Hospital 
  
 
Oct 1989- Nov 1997   
Cytology Department, St. Peter’s Hospital, Chertsey, Surrey. 
Job Title:   Chief Cytologist (MLSO 3**) 
Responsibilities:  In technical charge of the cytology department 
Achievements: Expanding cytology services from a small diagnostic 
unit to a full cervical screening service for North West 
Surrey Health Authority 
    Computerisation of the cytology department 
Involved in successful tendering for cytology work 
from two local private hospitals  
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Setting up a fine needle aspiration service at 
St.Peter’s Hospital 
Setting up a rapid, same day, breast cytology fine 
needle aspiration service at St.Peter’s Hospital 
  
Setting up a rapid, same day, fine needle 
aspiration service at a local private hospital  
Implementation of full quality control procedures 
in line with current guidelines 
1988- 1989   
Ravenscourt Laboratories Chiswick, London Department of Histology 
and Cytology 
Job Title:   Senior MLSO 
Responsibilities: Provide a diagnostic cytology and histology 
service underthe direction of the laboratory 
manager 
Achievements: Setting-up a comprehensive cytology service to 
this newly opened pathology laboratory 
Setting-up a diagnostic immunocytochemistry 
service 
Involved in successful tendering for cytology 
services  
 
1983-1988   
Department of Histopathology Royal Postgraduate Medical School - 
Hammersmith Hospital 
Job Title:   Trainee MLSO/ Basic Grade MLSO 
Responsibilities: To train in all aspects of diagnostic 
Histopathology including, electron microscopy, 
histology, neuropathology, immunocytochemistry 
and cytology 
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Achievements: Trained in all aspects of routine 
histo/cytopathology and obtained the relevant 
qualifications 
 
PROFESSIONAL ACTIVITIES 
Board member of Academy of Healthcare Science (AHCS), Cellular 
Sciences (2012-date) 
Board member for Cellular Science representing NHS South; National 
School of Healthcare Science (NSHCS) (2012-date) 
Chair of RCPath/Conjoint examination board; (2010 to 2013- three year fixed 
term) 
IBMS representative on NHSCSP “ABC 3” working party (2010-2012 project 
completed ) 
QA Scheme Organiser for Cervical cytology and Technical Quality 
Assurance Scheme for South East Coast (October 2010 - date) 
QA team member South East Coast; (2007 - date) 
IBMS Chief Examiner (Jan 2007 - date) 
IBMS representative on NCCETC (2005 – 2010) 
IBMS Deputy Chief Examiner for Cytology (2002 – 2007) 
Member of NHSCSP Working Party on Technical EQA in Cytology (1999-
2000)  
Examiner for NHSCSP Certificate Gynaecological Cytology (2000-date)  
Examiner for IBMS Examination in Interpretive and Diagnostic Cytopathology 
(1999-2000) 
Member of IBMS Scientific Advisory Panel (1999 - date) 
Examiner for RCPath/IBMS Certificate in Advance Practice (2001-date)  
CPA inspector (1997-2001) 
External examiner for the MSc course Clinical Cytopathology of the 
University of London (1997-2000) 
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Member of BSCC council (1997-2000) 
BSCC regional representative for Southern Cytology Society (1993-1998) 
Thames Valley Cytology Society meetings secretary (1994-1998). 
 
TEACHING EXPERIENCE 
Part-time lecturer on the IBMS FIBMS course at Bromley College of 
Technology (1992 – 1996) 
Invited lecturer for the MSc courses at University of Westminster and BSc 
courses at University of Surrey (2007 – date) 
Training and mentoring of cytology students at all levels; from experienced 
pathologists to trainee cytology screeners, at many training schools in UK 
including; Northwick Park Cytology Training School, the Welsh Cytology 
Training School, the Sheffield cytology training school, the Birmingham and 
the South West Cytology Training School (2001 - date) 
 
PRESENTATIONS 
Histopathology Study Day, London Deanery, 8 March 2013 “Serous 
effusions” 
British Association for Clinical Cytology, Keele University, September 2012 
“debate – Cytologist an endangered species” 
IBMS Congress ICC Birmingham September 2011 “case studies” 
IBMS Congress ICC Brimingham September 2011 Breakfast session   A 
Molecular Future for Cellular Pathology – an interactive debate (panel 
member) 
17th International Congress of Cytology May 2010 Edinburgh, Scotland 
“Extending the roles in Non-gynae-A UK perspective” 
IBMS Congress ICC Birmingham September 2009 “BMS role in reporting 
non-gynae” 
East of England Cytology Training Centre-March 2008 “Serous effusions” 
IBMS Congress ICC Birmingham September 2007 “The importance of 
cancer MDTs” 
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BSCC Northern Spring Tutorial-Manchester Royal Infirmary, March 2007 
“Biomedical Scientist Practitioners in Non-gynaecological Cytology: 
professional qualification, structure, training and examination format. 
Southern Cytology Society- Guys and St. Thomas’s Hospital October 2006, 
“Career planning for cytologists”-(Jointly with Mrs E Hewer) 
Scottish Association for Clinical Cytology, Perth May 2006 “BMS role in Non-
Gynae Cytology” 
IBMS Congress ICC Brimingham September 2005 “Serous effusions” 
IBMS Congress ICC Brimingham September 2005 “Career planning for 
cytologists”-(Jointly with Mrs E Hewer) 
IBMS Congress ICC Brimingham September 2005 “Case presentations” 
Birmingham Cytology Training Centre, July 2005 “Biomedical Scientist 
training” 
Thames Valley Cytology Society, St.Mary’s Hospital Dec 2004 “Cytology A 
dinosaur facing extinction” 
Southern Cytology Society October 2004-Kingston Hospital “Cytology; A 
dinosaur facing extinction” 
Thames Valley Cytology Society November 2002-Wexham Park Hospital 
“Advance Practice” 
Thames Valley Cytology Society March 2002, John Radcliffe Hospital “Can 
we grade dyskaryosis?” 
IBMS Congress 2001 Birmingham, “Advance Practitioner in Cytology- 
personal views” 
NAC 2001, Warwick, “Serous fluids” 
IBMS Congress 1999, Birmingham “Too many qualifications for cytologist” 
IBMS Congress 1999, Birmingham “Challenges in Serous fluid cytology 
Southern Cytology Society-October 1998, Ashford Hospital “Challenges in 
Serous Fluid Cytology” 
Thames Valley Cytology Society Nov 1997, Luton and Dunstable Hospital- 
“The American Way” 
Southern Cytology Society-October 1996- Poole Hospital- “Cytodiagnosis of 
thyroid disease” 
Southern Cytology Society- October 1995-Basingstoke- “Borderline changes” 
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Thames Valley Cytology Society- November 1994-Ealing Hospital- “Wise 
before the event” 
Cellular Pathology Update- April 1994 Guys Hospital- “Fine needle aspiration 
of head and neck” 
Southern Cytology Society- November 1991- Worthing Hospital “Computers 
in pathology” 
 
 
PUBLICATIONS 
Poster-European Respiratory society annual congress , 2012 Vienna , 
Mesothelioma diagnosis in a district general hospital; S. Sharma, K. Wimble, 
B. Shambayati, M. Wood (Chertsey, United Kingdom)  
 http://www.ers-education.org/ersMade/abstract_print_12/main_frameset.htm 
 
Modernizing Scientific Carriers (MSC) STP Cytopathology Learning Guide 
DOH in press 
Report co-author, NHSCSP 1-  Achievable standards, Benchmarks for 
reporting, and Criteria for evaluating cervical cytopathology (3rd Edition)  
June 2012 | ISBN 978 1 84463 081 3 
 
Oxford University Press - Cell structure and function, expected publication 
date 2013 Joint author chapter 6 Lungs: the cells of the respiratory system 
and chapter 12 Reproductive cells and gametogenesis 
 
 (US) Clinical Laboratory and  Laboratory Standards Institute 
GP23(Electronic Document) Nongynecologic Cytologic Specimens: 
Collection and Cytopreparatory Techniques; Approved Guideline – In press 
2012 
 
B Shambayati. Self assessments in Lower respiratory tract cytology 
.Diagnostic Histopathology Volume 17:2 February 2011 
Poster-European Respiratory society annual congress , Amsterdam 2011, 
Does immediate cytological analysis at bronchoscopy lead to reduced 
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number of biopsies? 
C. Eruchie, M. Manalo, B. Shambayati, P. Murray (Surrey, United Kingdom 
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